Aspergillus fumigatus and Aspergillosis

SUMMARY Aspergillus fumigatus is one of the most ubiquitous of the airborne saprophytic fungi. Humans and animals constantly inhale numerous conidia of this fungus. The conidia are normally eliminated in the immunocompetent host by innate immune mechanisms, and aspergilloma and allergic bronchopulmonary aspergillosis, uncommon clinical syndromes, are the only infections observed in such hosts. Thus, A. fumigatus was considered for years to be a weak pathogen. With increases in the number of immunosuppressed patients, however, there has been a dramatic increase in severe and usually fatal invasive aspergillosis, now the most common mold infection worldwide. In this review, the focus is on the biology of A. fumigatus and the diseases it causes. Included are discussions of (i) genomic and molecular characterization of the organism, (ii) clinical and laboratory methods available for the diagnosis of aspergillosis in immunocompetent and immunocompromised hosts, (iii) identification of host and fungal factors that play a role in the establishment of the fungus in vivo, and (iv) problems associated with antifungal therapy.

[1]  Nina Singh,et al.  Infections in solid organ transplant recipients. , 2000, Current opinion in infectious diseases.

[2]  J. Latgé,et al.  Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  L. Collette,et al.  An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  J. Frisvad,et al.  Evolutionary relationships in Aspergillus section Fumigati inferred from partial beta-tubulin and hydrophobin DNA sequences , 1998 .

[5]  J. Humbert,et al.  Microsatellite Markers for Typing Aspergillus fumigatus Isolates , 1998, Journal of Clinical Microbiology.

[6]  D. Holden,et al.  Insertional mutagenesis of Aspergillus fumigatus , 1998, Molecular and General Genetics MGG.

[7]  P. Kvale,et al.  Risk Factors and Outcomes Associated With Identification of Aspergillus in Respiratory Specimens From Persons With HIV Disease , 1998 .

[8]  J. Rich,et al.  Pulmonary aspergillosis and invasive disease in AIDS: review of 342 cases. , 1998, Chest.

[9]  L. Mayer,et al.  Utility of Random Amplified Polymorphic DNA PCR and TaqMan Automated Detection in Molecular Identification ofAspergillus fumigatus , 1998, Journal of Clinical Microbiology.

[10]  K. Kwon-Chung,et al.  The Developmentally Regulated alb1 Gene ofAspergillus fumigatus: Its Role in Modulation of Conidial Morphology and Virulence , 1998, Journal of bacteriology.

[11]  J. Latgé,et al.  Molecular Typing of Environmental and Patient Isolates of Aspergillus fumigatus from Various Hospital Settings , 1998, Journal of Clinical Microbiology.

[12]  C. Rieux,et al.  Comparison of serum galactomannan antigen detection and competitive polymerase chain reaction for diagnosing invasive aspergillosis. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  Paul E. Verweij,et al.  Detection of Antigen in Sera of Patients with Invasive Aspergillosis: Intra- and Interlaboratory Reproducibility , 1998, Journal of Clinical Microbiology.

[14]  D. Stevens,et al.  Combination immunotherapy and antifungal chemotherapy. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  J. Nemunaitis,et al.  Use of macrophage colony-stimulating factor in the treatment of fungal infections. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  D. Hospenthal,et al.  Concentrations of airborne Aspergillus compared to the incidence of invasive aspergillosis: lack of correlation. , 1998, Medical mycology.

[17]  C. Viscoli Prevention of aspergillosis in bone marrow transplantation. , 1998, The Journal of infectious diseases.

[18]  M. T. V. van Rens,et al.  Detection of immunoglobulins G and A to Aspergillus fumigatus by immunoblot analysis for monitoring Aspergillus-induced lung diseases. , 1998, The European respiratory journal.

[19]  J. Rowe Treatment of acute myeloid leukemia with cytokines: effect on duration of neutropenia and response to infections. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  E. Anaissie,et al.  The potential role of cytokine therapy for fungal infections in patients with cancer: is recovery from neutropenia all that is needed? , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  A. Mencacci,et al.  Cytokine- and T-helper-dependent immunity in murine aspergillosis. , 1998, Research in immunology.

[22]  T. Walsh,et al.  Pulmonary host defences against Aspergillus fumigatus. , 1998, Research in immunology.

[23]  J. Cornish,et al.  Molecular Epidemiological Study ofAspergillus fumigatus in a Bone Marrow Transplantation Unit by PCR Amplification of Ribosomal Intergenic Spacer Sequences , 1998, Journal of Clinical Microbiology.

[24]  E. Anaissie,et al.  Cytokines as therapy for opportunistic fungal infections. , 1998, Research in immunology.

[25]  C. Salerno,et al.  Surgical therapy for pulmonary aspergillosis in immunocompromised patients. , 1998, The Annals of thoracic surgery.

[26]  D. Pittet,et al.  Invasive Aspergillosis Clinical Features of 35 Proven Cases at a Single Institution , 1998, Medicine.

[27]  D. De Bacquer,et al.  Impact of previous aspergillosis on the outcome of bone marrow transplantation. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  V. Kurup,et al.  Cytokines in allergic bronchopulmonary aspergillosis. , 1998, Research in immunology.

[29]  S. Holland,et al.  Virulence of catalase-deficient aspergillus nidulans in p47(phox)-/- mice. Implications for fungal pathogenicity and host defense in chronic granulomatous disease. , 1998, The Journal of clinical investigation.

[30]  R. Bowden,et al.  Panfungal PCR Assay for Detection of Fungal Infection in Human Blood Specimens , 1998, Journal of Clinical Microbiology.

[31]  C. Viscoli,et al.  Comparison of an enzyme immunoassay and a latex agglutination system for the diagnosis of invasive aspergillosis in bone marrow transplant recipients , 1998, Bone Marrow Transplantation.

[32]  C. d’Enfert,et al.  Development of a homologous transformation system for the human pathogenic fungus Aspergillus fumigatus based on the pyrG gene encoding orotidine 5′′-monophosphate decarboxylase , 1998, Current Genetics.

[33]  J Ramis,et al.  New azole antifungals. 3. Synthesis and antifungal activity of 3-substituted-4(3H)-quinazolinones. , 1998, Journal of medicinal chemistry.

[34]  R. Crameri,et al.  Differential IgE recognition of recombinant Aspergillus fumigatus allergens by cystic fibrosis patients with allergic bronchopulmonary aspergillosis or Aspergillus allergy , 1998, European journal of immunology.

[35]  T. C. White,et al.  Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance , 1998, Clinical Microbiology Reviews.

[36]  N. Müller,et al.  Invasive aspergillosis in the immunocompromised host: utility of computed tomography and bronchoalveolar lavage. , 1998, Clinical radiology.

[37]  D. Denning,et al.  Efficacy of LY303366 against Amphotericin B-Susceptible and -Resistant Aspergillus fumigatus in a Murine Model of Invasive Aspergillosis , 1998, Antimicrobial Agents and Chemotherapy.

[38]  I. Ahmad,et al.  In Vitro and In Vivo Antifungal Activity of Amphotericin B Lipid Complex: Are Phospholipases Important? , 1998, Antimicrobial Agents and Chemotherapy.

[39]  A. Lewin,et al.  Inhibition of RNA Synthesis as a Therapeutic Strategy against Aspergillus and Fusarium: Demonstration of In Vitro Synergy between Rifabutin and Amphotericin B , 1998, Antimicrobial Agents and Chemotherapy.

[40]  M. Schuyler The Th1/Th2 paradigm in allergic bronchopulmonary aspergillosis. , 1998, The Journal of laboratory and clinical medicine.

[41]  T. Meshulam,et al.  Human Platelets Damage Aspergillus fumigatus Hyphae and May Supplement Killing by Neutrophils , 1998, Infection and Immunity.

[42]  V. Kurup,et al.  IgE down regulation and cytokine induction by Aspergillus antigens in human allergic bronchopulmonary aspergillosis. , 1998, The Journal of laboratory and clinical medicine.

[43]  A. Mehta,et al.  Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[44]  T. Patterson Approaches to therapy for invasive mycoses--the role of amphotericin B. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[45]  M. Ghannoum,et al.  Evaluation of Possible Correlations between Antifungal Susceptibilities of Filamentous Fungi In Vitro and Antifungal Treatment Outcomes in Animal Infection Models , 1998, Antimicrobial Agents and Chemotherapy.

[46]  M. Ovejero,et al.  The recombinant antigen ASPND1r from Aspergillus nidulans is specifically recognized by sera from patients with aspergilloma. , 1998, Microbiology.

[47]  F. Pien,et al.  Amphotericin B use in a community hospital, with special emphasis on side effects. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[48]  J. Capobianco,et al.  Cellular Accumulation, Localization, and Activity of a Synthetic Cyclopeptamine in Fungi , 1998, Antimicrobial Agents and Chemotherapy.

[49]  R. Crameri Recombinant Aspergillus fumigatus Allergens: From the Nucleotide Sequences to Clinical Applications , 1998, International Archives of Allergy and Immunology.

[50]  D. Geiser,et al.  Cryptic speciation and recombination in the aflatoxin-producing fungus Aspergillus flavus. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[51]  A. Polak Experimental models in antifungal chemotherapy , 1998, Mycoses.

[52]  S. Kohno,et al.  Long-Circulating Immunoliposomal Amphotericin B against Invasive Pulmonary Aspergillosis in Mice , 1998, Antimicrobial Agents and Chemotherapy.

[53]  M. Hensel,et al.  The role of the Aspergillus fumigatus areA gene in invasive pulmonary aspergillosis. , 1998, Molecular & general genetics : MGG.

[54]  R. N. Brogden,et al.  Liposomal amphotericin B. Therapeutic use in the management of fungal infections and visceral leishmaniasis. , 1998, Drugs.

[55]  S. Diederich,et al.  Aspergillus infection of the respiratory tract after lung transplantation: chest radiographic and CT findings , 1998, European Radiology.

[56]  E. Anaissie,et al.  Aspergillus fumigatus conidia induce a Th1-type cytokine response. , 1997, The Journal of infectious diseases.

[57]  V. Kurup,et al.  Immunopathologic responses to Aspergillus antigen in interleukin-4 knockout mice. , 1997, The Journal of laboratory and clinical medicine.

[58]  S. Bhakdi,et al.  Isolation and characterization of a pigmentless-conidium mutant of Aspergillus fumigatus with altered conidial surface and reduced virulence , 1997, Infection and immunity.

[59]  V. Kurup,et al.  Anti‐interleukin (IL)‐4 and ‐IL‐5 antibodies downregulate IgE and eosinophilia in mice exposed to Aspergillus antigens , 1997, Allergy.

[60]  L. Pagano,et al.  The role of bronchoalveolar lavage in the microbiological diagnosis of pneumonia in patients with haematological malignancies. , 1997, Annals of medicine.

[61]  A. Csekeő,et al.  Surgery for pulmonary aspergillosis. , 1997, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[62]  M. Wolff,et al.  Morphological characteristics of Aspergillus fumigatus strains isolated from patient samples , 1997, Mycoses.

[63]  J. Severens,et al.  Two strategies for managing invasive aspergillosis: a decision analysis. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[64]  J. Smith,et al.  Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis , 1997, Antimicrobial agents and chemotherapy.

[65]  J. Latgé,et al.  Value of galactomannan detection by sandwich enzyme-linked immunosorbent assay in the early diagnosis and follow-up of invasive aspergillosis , 1997 .

[66]  J. Latgé,et al.  Cloning and disruption of the antigenic catalase gene of Aspergillus fumigatus , 1997, Infection and immunity.

[67]  K. Savik,et al.  Aspergillus airway colonization and invasive disease after lung transplantation. , 1997, Chest.

[68]  L. Palmberg,et al.  Reaction of human alveolar macrophages to exposure to Aspergillus fumigatus and inert particles. , 1997, Environmental research.

[69]  J. Smith,et al.  In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872) , 1997, Antimicrobial agents and chemotherapy.

[70]  A. Bernard,et al.  Surgical management of invasive pulmonary aspergillosis in neutropenic patients. , 1997, The Annals of thoracic surgery.

[71]  R. Kerschmann,et al.  Pulmonary aspergillosis in acquired immune deficiency syndrome: autopsy study of an emerging pulmonary complication of human immunodeficiency virus infection. , 1997, Human pathology.

[72]  D. T. Cody,et al.  Effects of Aspergillus fumigatus and Alternaria alternata on Human Ciliated Epithelium in Vitro , 1997, The Laryngoscope.

[73]  D. Kirschmann,et al.  The association of HLA-DR alleles and T cell activation with allergic bronchopulmonary aspergillosis. , 1997, Journal of immunology.

[74]  K. Kwon-Chung,et al.  Aspergillus fumigatus arp1 modulates conidial pigmentation and complement deposition , 1997, Molecular microbiology.

[75]  P. Skatrud,et al.  An electrophoretic molecular karyotype of a clinical isolate of Aspergillus fumigatus and localization of the MDR-like genes AfuMDR1 and AfuMDR2. , 1997, Diagnostic microbiology and infectious disease.

[76]  K. Montone,et al.  Detection of Aspergillus Ribosomal RNA Using Biotinylated Oligonucleotide Probes , 1997, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[77]  E. Anaissie,et al.  Activity of liposomal nystatin against disseminated Aspergillus fumigatus infection in neutropenic mice , 1997, Antimicrobial agents and chemotherapy.

[78]  D. Denning,et al.  Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection. , 1997, The Journal of antimicrobial chemotherapy.

[79]  L. Kaufman,et al.  Immunohistologic identification of Aspergillus spp. and other hyaline fungi by using polyclonal fluorescent antibodies , 1997, Journal of clinical microbiology.

[80]  K. Donaldson,et al.  Diffusible component from the spore surface of the fungus Aspergillus fumigatus which inhibits the macrophage oxidative burst is distinct from gliotoxin and other hyphal toxins. , 1997, Thorax.

[81]  Yih-Leong Chang,et al.  Surgical treatment for pulmonary aspergilloma: a 28 year experience , 1998 .

[82]  J. Latgé,et al.  Genetic diversity among clinical and environmental isolates of Aspergillus fumigatus , 1997, Infection and immunity.

[83]  U. Kishore,et al.  Binding of pulmonary surfactant proteins A and D to Aspergillus fumigatus conidia enhances phagocytosis and killing by human neutrophils and alveolar macrophages , 1997, Infection and immunity.

[84]  A. Beauvais,et al.  Dipeptidyl-peptidase IV secreted by Aspergillus fumigatus, a fungus pathogenic to humans , 1997, Infection and immunity.

[85]  J. Latgé,et al.  Serum Aspergillus galactomannan antigen testing by sandwich ELISA: practical use in neutropenic patients. , 1997, The Journal of infection.

[86]  I. V. van Gameren,et al.  Pyridoxin‐responsive anaemia in a patient with a history of polycythaemia vera , 1997, Journal of internal medicine.

[87]  M. Mallié,et al.  Murine macrophage elastolytic activity induced by Aspergillus fumigatusstrains in vitro: evidence of the expression of two macrophage-induced protease genes. , 1997, Canadian journal of microbiology.

[88]  C. Cantor,et al.  Deoxyribonucleic acids as unique markers in molecular detection. , 1997, Genetic analysis : biomolecular engineering.

[89]  C. d’Enfert,et al.  The Aspergillus fumigatus mepB gene encodes an 82 kDa intracellular metalloproteinase structurally related to mammalian thimet oligopeptidases. , 1997, Microbiology.

[90]  P. Hiemstra,et al.  Proteases from Aspergillus fumigatus induce release of proinflammatory cytokines and cell detachment in airway epithelial cell lines. , 1997, The Journal of infectious diseases.

[91]  S. Singhal,et al.  Amphotericin B lipid complex (ABLC) for the treatment of confirmed or presumed fungal infections in immunocompromised patients with hematologic malignancies , 1997, Bone Marrow Transplantation.

[92]  J. Lissitzky,et al.  Sialic acid-dependent recognition of laminin and fibrinogen by Aspergillus fumigatus conidia , 1997, Infection and immunity.

[93]  J. Donnelly Is there a rationale for the use of antimicrobial prophylaxis in neutropenic patients? , 1997, Journal of internal medicine. Supplement.

[94]  K. Yuen,et al.  Stage-specific manifestation of mold infections in bone marrow transplant recipients: risk factors and clinical significance of positive concentrated smears. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[95]  D. Denning,et al.  Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus , 1997, Antimicrobial agents and chemotherapy.

[96]  V. Kurup,et al.  Purification of a major allergen, Asp f 2 binding to IgE in allergic bronchopulmonary aspergillosis, from culture filtrate of Aspergillus fumigatus. , 1997, The Journal of allergy and clinical immunology.

[97]  W. Leisenring,et al.  Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. , 1997, The Journal of infectious diseases.

[98]  H. Einsele,et al.  Detection and identification of fungal pathogens in blood by using molecular probes , 1997, Journal of clinical microbiology.

[99]  S. Kelly,et al.  Itraconazole resistance in Aspergillus fumigatus , 1997, Antimicrobial agents and chemotherapy.

[100]  D. Denning,et al.  Diagnostic and Therapeutic Strategies for Invasive Aspergillosis , 1997 .

[101]  U. Reichard,et al.  Virulence of an aspergillopepsin-deficient mutant of Aspergillus fumigatus and evidence for another aspartic proteinase linked to the fungal cell wall. , 1997, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[102]  Mehboob Alam,et al.  Chronic invasive aspergillosis in apparently immunocompetent hosts. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[103]  W. Liles,et al.  Granulocyte colony-stimulating factor administered in vivo augments neutrophil-mediated activity against opportunistic fungal pathogens. , 1997, The Journal of infectious diseases.

[104]  J. Latgé,et al.  Internalization of Aspergillus fumigatus conidia by epithelial and endothelial cells , 1997, Infection and immunity.

[105]  M. Ovejero,et al.  Characterization of the Aspergillus nidulans aspnd1 gene demonstrates that the ASPND1 antigen, which it encodes, and several Aspergillus fumigatus immunodominant antigens belong to the same family , 1997, Infection and immunity.

[106]  M. Leach,et al.  Interleukin-10 Is a Natural Suppressor of Cytokine Production and Inflammation in a Murine Model of Allergic Bronchopulmonary Aspergillosis , 1997, The Journal of experimental medicine.

[107]  A. Beauvais,et al.  Biochemical and Antigenic Characterization of a New Dipeptidyl-Peptidase Isolated from Aspergillus fumigatus* , 1997, The Journal of Biological Chemistry.

[108]  W. Rom,et al.  Pulmonary aspergilloma and AIDS. A comparison of HIV-infected and HIV-negative individuals. , 1997, Chest.

[109]  D. Armstrong,et al.  Activity of voriconazole (UK-109,496) against clinical isolates of Aspergillus species and its effectiveness in an experimental model of invasive pulmonary aspergillosis , 1997, Antimicrobial agents and chemotherapy.

[110]  V. Kurup,et al.  Role of particulate antigens of Aspergillus in murine eosinophilia. , 1997, International archives of allergy and immunology.

[111]  J. Meis,et al.  Serial monitoring ofAspergillus antigen in the early diagnosis of invasive aspergillosis. Preliminary investigations with two examples , 1997, Infection.

[112]  C. Douglas,et al.  Lipopeptide inhibitors of fungal glucan synthase. , 1997, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[113]  M. van de Rijn,et al.  Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[114]  J. Latgé,et al.  Th1 and Th2 cytokines in mice with invasive aspergillosis , 1997, Infection and immunity.

[115]  N. Giri,et al.  Invasive aspergillosis in human immunodeficiency virus-infected children. , 1997, The Pediatric infectious disease journal.

[116]  N. Gow,et al.  Aspergillus fumigatus chsE: a gene related to CHS3 of Saccharomyces cerevisiae and important for hyphal growth and conidiophore development but not pathogenicity. , 1997, Fungal genetics and biology : FG & B.

[117]  D. Armstrong,et al.  Efficacy of prophylactic aerosol amphotericin B lipid complex in a rat model of pulmonary aspergillosis , 1997, Antimicrobial agents and chemotherapy.

[118]  B. Lebeau,et al.  Molecular typing of Aspergillus fumigatus strains by sequence-specific DNA primer (SSDP) analysis. , 1997, FEMS immunology and medical microbiology.

[119]  T. Patterson,et al.  Hospital Epidemiologic Surveillance for Invasive Aspergillosis: Patient Demographics and the Utility of Antigen Detection , 1997, Infection Control & Hospital Epidemiology.

[120]  M. Dinauer,et al.  Absence of Respiratory Burst in X-linked Chronic Granulomatous Disease Mice Leads to Abnormalities in Both Host Defense and Inflammatory Response to Aspergillus fumigatus , 1997, The Journal of experimental medicine.

[121]  H. Kakeya,et al.  Novel mammalian cell cycle inhibitors, spirotryprostatins A and B, produced by Aspergillus fumigatus, which inhibit mammalian cell cycle at G2/M phase☆ , 1997 .

[122]  T. Walsh,et al.  IL-10 exerts suppressive and enhancing effects on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. , 1997, Journal of immunology.

[123]  M. Martín,et al.  Comparison of voriconazole (UK-109,496) and itraconazole in prevention and treatment of Aspergillus fumigatus endocarditis in guinea pigs , 1997, Antimicrobial agents and chemotherapy.

[124]  R. Filmon,et al.  Expression and identification of a laminin-binding protein in Aspergillus fumigatus conidia , 1997, Infection and immunity.

[125]  J. Rex,et al.  Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi , 1997, Journal of clinical microbiology.

[126]  J. Meis,et al.  Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan , 1997, Journal of clinical microbiology.

[127]  A. Bernard,et al.  Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[128]  J. Latgé,et al.  Longitudinal study of Aspergillus fumigatus strains isolated from cystic fibrosis patients. , 1997, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology.

[129]  A. Beauvais,et al.  Purification and characterization of an endo-1,3-beta-glucanase from Aspergillus fumigatus. , 1997, European journal of biochemistry.

[130]  D. Carter,et al.  Analysis of the internal transcribed spacer regions of ribosomal DNA in common airborne allergenic fungi , 1997, Electrophoresis.

[131]  J. M. Costa,et al.  Detection of Aspergillus DNA in bronchoalveolar lavage fluid of AIDS patients by the polymerase chain reaction. , 1997, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology.

[132]  E. Chryssanthou In vitro susceptibility of respiratory isolates of Aspergillus species to itraconazole and amphotericin B. acquired resistance to itraconazole. , 1997, Scandinavian journal of infectious diseases.

[133]  K. High,et al.  Invasive aspergillosis in mice immunosuppressed with cyclosporin A, tacrolimus (FK506), or sirolimus (rapamycin). , 1997, The Journal of infectious diseases.

[134]  H. Kantarjian,et al.  Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor-elicited white blood cell transfusions: a pilot study , 1997, Leukemia.

[135]  J. Apperley,et al.  Paranasal sinusitis following allogeneic bone marrow transplant , 1997, Bone Marrow Transplantation.

[136]  T. Burns,et al.  Successful program to prevent aspergillus infections in children undergoing marrow transplantation: use of nasal amphotericin , 1997, Bone Marrow Transplantation.

[137]  R. Washburn,et al.  Binding and germination of Aspergillus fumigatus conidia on cultured A549 pneumocytes. , 1997, The Journal of infectious diseases.

[138]  V. Kurup,et al.  Aspergillus fumigatus peptides differentially express Th1 and Th2 cytokines , 1996, Peptides.

[139]  L. S. Broderick,et al.  Pulmonary aspergillosis: a spectrum of disease. , 1996, Critical reviews in diagnostic imaging.

[140]  J. Lidholm,et al.  Automated specific IgE assay with recombinant allergens: evaluation of the recombinant Aspergillus fumigatus allergen I in the Pharmacia CAP System , 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[141]  J. O'connor,et al.  Binding of extracellular matrix proteins to Aspergillus fumigatus conidia , 1996, Infection and immunity.

[142]  K. Donaldson,et al.  Binding of Aspergillus fumigatus spores to lung epithelial cells and basement membrane proteins: relevance to the asthmatic lung. , 1996, Thorax.

[143]  T. Rogers,et al.  Purification and characterization of a 93 kDa Aspergillus fumigatus antigen with diagnostic potential. , 1996, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[144]  M. Bossé,et al.  Dexamethasone and cyclosporin A modulation of cytokine expression and specific antibody synthesis in an allergic bronchopulmonary aspergillosis murine model , 1996, European journal of clinical investigation.

[145]  A. Yinnon,et al.  Changes in the natural history of invasive pulmonary aspergillosis in neutropenic leukemic patients. , 1996, Israel journal of medical sciences.

[146]  J. Latgé,et al.  A Novel β-(1, 2, 3)-Glucanosyltransferase from the Cell Wall of Aspergillus fumigatus* , 1996, The Journal of Biological Chemistry.

[147]  K. Yokota,et al.  Binding assay of low density lipoprotein to Asp-hemolysin from Aspergillus fumigatus. , 1996, Biological & pharmaceutical bulletin.

[148]  J. Bolard,et al.  Carrier effects on biological activity of amphotericin B , 1996, Clinical microbiology reviews.

[149]  B. Lebeau,et al.  Multicentric epidemiological study of Aspergillus fumigatus isolates by multilocus enzyme electrophoresis , 1996, Journal of clinical microbiology.

[150]  M. Nasu,et al.  PCR detection of DNA specific for Aspergillus species in serum of patients with invasive aspergillosis , 1996, Journal of clinical microbiology.

[151]  J. Latgé,et al.  Attenuated virulence of uridine-uracil auxotrophs of Aspergillus fumigatus , 1996, Infection and immunity.

[152]  J. Latgé,et al.  Genotypic characterization of sequential Aspergillus fumigatus isolates from patients with cystic fibrosis , 1996, Journal of clinical microbiology.

[153]  S. Fridkin,et al.  Epidemiology of nosocomial fungal infections , 1996, Clinical microbiology reviews.

[154]  M. Clerici,et al.  Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases , 1996, Clinical microbiology reviews.

[155]  B. Klein,et al.  Virulence Factors of Medically Important Fungi , 1996 .

[156]  P. Robbins,et al.  Cloning and characterization of chsD, a chitin synthase-like gene of Aspergillus fumigatus. , 1996, FEMS microbiology letters.

[157]  D. Denning Therapeutic outcome in invasive aspergillosis. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[158]  G. Alangaden,et al.  A comparative study of the broth micro- and macro-dilution techniques for the determination of the in vitro susceptibility of Aspergillus fumigatus. , 1996, Canadian journal of microbiology.

[159]  L. Pagano,et al.  Localization of aspergillosis to the central nervous system among patients with acute leukemia: report of 14 cases. Gruppo Italiano Malattie Ematologiche dell'Adulto Infection Program. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[160]  F. Odds,et al.  Chitinase levels in guinea pig blood are increased after systemic infection with Aspergillus fumigatus. , 1996, Glycobiology.

[161]  P. Ambroise‐Thomas,et al.  Variation in virulence of Aspergillus fumigatus strains in a murine model of invasive pulmonary aspergillosis. , 1996, Journal of medical microbiology.

[162]  A. Schaffner,et al.  Comparison of the antimicrobial activity of deactivated human macrophages challenged with Aspergillus fumigatus and Listeria monocytogenes. , 1996, The Journal of infectious diseases.

[163]  P. Waring,et al.  Exacerbation of invasive aspergillosis by the immunosuppressive fungal metabolite, gliotoxin , 1996, Immunology and cell biology.

[164]  J. Nielsen,et al.  Isolation of a gene involved in 1,3-beta-glucan synthesis in Aspergillus nidulans and purification of the corresponding protein , 1996, Journal of bacteriology.

[165]  R. Hay,et al.  The Cu,Zn superoxide dismutases of Aspergillus flavus, Aspergillus niger, Aspergillus nidulans, and Aspergillus terreus: purification and biochemical comparison with the Aspergillus fumigatus Cu,Zn superoxide dismutase , 1996, Infection and immunity.

[166]  T. S. van der Werf,et al.  Serodiagnosis and Monitoring of Aspergillus Infections after Lung Transplantation , 1996, Annals of Internal Medicine.

[167]  R. Slavin,et al.  A 12-year longitudinal study of Aspergillus sensitivity in patients with cystic fibrosis. , 1996, Chest.

[168]  S. Bhakdi,et al.  Colorimetric susceptibility testing for Aspergillus fumigatus: comparison of menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide and Alamar blue tests , 1996, Journal of clinical microbiology.

[169]  J. Latgé,et al.  Detection of galactomannan and complement activation in the pregnant mouse during experimental systemic aspergillosis , 1996, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[170]  K. Donaldson,et al.  Inhibition of the transcription factors NF-kappa B and AP-1 underlies loss of cytokine gene expression in rat alveolar macrophages treated with a diffusible product from the spores of Aspergillus fumigatus. , 1996, American journal of respiratory cell and molecular biology.

[171]  K. Moffat,et al.  Insights into specificity of cleavage and mechanism of cell entry from the crystal structure of the highly specific Aspergillus ribotoxin, restrictocin. , 1996, Structure.

[172]  J. Warner,et al.  Improved diagnosis of allergic bronchopulmonary aspergillosis with gp66 (formerly antigen 7) of Aspergillus fumigatus for specific IgE detection. , 1996, The Journal of allergy and clinical immunology.

[173]  M. Casanova,et al.  Cell wall protein and glycoprotein constituents of Aspergillus fumigatus that bind to polystyrene may be responsible for the cell surface hydrophobicity of the mycelium. , 1996, Microbiology.

[174]  P. Kolattukudy,et al.  Disruption of the serine proteinase gene (sep) in Aspergillus flavus leads to a compensatory increase in the expression of a metalloproteinase gene (mep20) , 1996, Journal of bacteriology.

[175]  R. Jaussi,et al.  Humoral and cell-mediated autoimmunity in allergy to Aspergillus fumigatus , 1996, Journal of Experimental Medicine.

[176]  J. Lister Amphotericin B Lipid Complex (Abelcet®) in the treatment of invasive mycoses: the North American experience , 1996, European journal of haematology. Supplementum.

[177]  C. d’Enfert Selection of multiple disruption events in Aspergillus fumigatus using the orotidine-5′-decarboxylase gene, pyrG, as a unique transformation marker , 1996, Current Genetics.

[178]  A. Niimi,et al.  Murine model of invasive pulmonary aspergillosis following an earlier stage, noninvasive Aspergillus infection , 1996, Journal of clinical microbiology.

[179]  R. Slavin,et al.  T cell subsets, epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis. , 1996, The Journal of clinical investigation.

[180]  N. Gow,et al.  The Aspergillus fumigatus chsC and chsG genes encode Class III chitin synthases with different functions , 1996, Molecular microbiology.

[181]  R. Crameri,et al.  Cloning Aspergillus fumigatus allergens by the pJuFo filamentous phage display system. , 1996, International archives of allergy and immunology.

[182]  T. Walsh,et al.  N-acetylcysteine inhibits germination of conidia and growth of Aspergillus spp. and Fusarium spp , 1996, Antimicrobial agents and chemotherapy.

[183]  T. Walsh,et al.  Lipid formulations of amphotericin B: recent progress and future directions. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[184]  B. Gellin,et al.  Fungal infections: a growing threat. , 1996, Public health reports.

[185]  M. Hensel,et al.  Molecular genetic approaches for the study of virulence in both pathogenic bacteria and fungi. , 1996, Microbiology.

[186]  K. Yokota,et al.  Apolipoprotein B inhibits the hemolytic activity of asp-hemolysin from Aspergillus fumigatus. , 1996, Biological & pharmaceutical bulletin.

[187]  J. Latgé,et al.  Afut1, a retrotransposon-like element from Aspergillus fumigatus. , 1996, Nucleic acids research.

[188]  J. Meis,et al.  Prospects for the early diagnosis of invasive aspergillosis in the immunocompromised patient , 1996 .

[189]  T. Sirakova,et al.  Specific inhibition of mature fungal serine proteinases and metalloproteinases by their propeptides , 1996, Journal of bacteriology.

[190]  F. Ricolfi,et al.  Acquired ciliary abnormalities of nasal mucosa in marrow recipients. , 1996, Bone marrow transplantation.

[191]  S. Spector,et al.  Disease patterns and survival after acquired immunodeficiency syndrome diagnosis in human immunodeficiency virus-infected children. , 1996, The Pediatric infectious disease journal.

[192]  A. Davies,et al.  Clostridium difficile in a healthcare worker. , 1996, The Journal of hospital infection.

[193]  K. Donaldson,et al.  Inhibition of the alveolar macrophage oxidative burst by a diffusible component from the surface of the spores of the fungus Aspergillus fumigatus. , 1996, Thorax.

[194]  M. Laviolette,et al.  Immunohistochemical detection of GM‐CSF, IL‐4 and IL‐5 in a murine model of allergic bronchopulmonary aspergillosis , 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[195]  K. Schulze-Osthoff,et al.  The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappaB , 1996, The Journal of experimental medicine.

[196]  J. O'connor,et al.  Binding of human fibronectin to Aspergillus fumigatus conidia , 1996, Infection and immunity.

[197]  J. Maurer,et al.  Aspergillus infection in single and double lung transplant recipients. , 1996, Transplantation.

[198]  V. Kurup,et al.  Molecular cloning and expression of a recombinant Aspergillus fumigatus protein Asp f II with significant immunoglobulin E reactivity in allergic bronchopulmonary aspergillosis. , 1996, The Journal of laboratory and clinical medicine.

[199]  J. Latgé,et al.  Prospective sandwich enzyme-linked immunosorbent assay for serum galactomannan: early predictive value and clinical use in invasive aspergillosis. , 1996, The Pediatric infectious disease journal.

[200]  G. Robson,et al.  Evidence of multiple extracellular phospholipase activities of Aspergillus fumigatus , 1996, Infection and immunity.

[201]  Müller Nl,et al.  CT manifestations of pulmonary aspergillosis. , 1996 .

[202]  J. Horvath,et al.  The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis. , 1996, The American journal of medicine.

[203]  M. Laviolette,et al.  Tumor necrosis factor-alpha and interleukin-1 alpha expression in a murine model of allergic bronchopulmonary aspergillosis. , 1996, Laboratory animal science.

[204]  R. Amitani,et al.  Suppressive effects of Aspergillus fumigatus culture filtrates on human alveolar macrophages and polymorphonuclear leucocytes. , 1996, The European respiratory journal.

[205]  A. van Belkum,et al.  Molecular epidemiology of apparent outbreak of invasive aspergillosis in a hematology ward , 1996, Journal of clinical microbiology.

[206]  T. Kozel,et al.  Activation of the complement system by pathogenic fungi , 1996, Clinical microbiology reviews.

[207]  R. Kappe,et al.  Evaluation of eight antibody tests and one antigen test for the diagnosis of invasive aspergillosis , 1996, Mycoses.

[208]  K. Gull,et al.  Molecular typing by random amplification of polymorphic DNA and M13 southern hybridization of related paired isolates of Aspergillus fumigatus , 1996, Journal of clinical microbiology.

[209]  L. Kaufman,et al.  Diagnosis of systemic mycoses by specific immunohistochemical tests , 1996, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[210]  R. Locksley,et al.  Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity [published erratum appears in J Exp Med 1997 May 5;185(9):1715] , 1996, The Journal of experimental medicine.

[211]  T. Walsh,et al.  Granulocyte-macrophage colony-stimulating factor and interferon-gamma prevent dexamethasone-induced immunosuppression of antifungal monocyte activity against Aspergillus fumigatus hyphae. , 1996, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[212]  F. Traoré,et al.  Typage moléculaire d'Aspergillus fumigatus par la technique de Random Amplified Polymorphic DNA (RAPD) : Applications épidémiologiques en milieu hospitalier , 1996 .

[213]  N. Müller,et al.  CT manifestations of pulmonary aspergillosis. , 1996, Critical reviews in diagnostic imaging.

[214]  G. Menz,et al.  [Allergic bronchopulmonary aspergillosis]. , 1996, Pneumologie.

[215]  I. Ho,et al.  GABA(A) Receptor-Related Chloride Flux of Rats Receiving Continuous Intracerebroventricular Infusion of Pentobarbital. , 1996, Journal of biomedical science.

[216]  D. Taramelli,et al.  Production of cytokines by alveolar and peritoneal macrophages stimulated by Aspergillus fumigatus conidia or hyphae. , 1996, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[217]  H. Goto,et al.  Evaluation of the diagnostic value of the measurement of (1-->3)-beta-D-glucan in patients with pulmonary aspergillosis. , 1996, Respiration; international review of thoracic diseases.

[218]  K. de Beule,et al.  Itraconazole: pharmacology, clinical experience and future development. , 1996, International journal of antimicrobial agents.

[219]  R. Poe,et al.  Pulmonary mycetoma due to Candida albicans: case report and review. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[220]  M. Hensel,et al.  Regulation of fungal extracellular proteases and their role in mammalian pathogenesis , 1995 .

[221]  A. Beauvais,et al.  Antigens of Aspergillus fumigatus expressed during infection , 1995 .

[222]  J. Latgé,et al.  THE SECRETED PROTEASES OF PATHOGENIC SPECIES OF ASPERGILLUS AND THEIR POSSIBLE ROLE IN VIRULENCE , 1995 .

[223]  Hongyung Choi,et al.  Interferon-γ and Tumor Necrosis Factor-α Protect Mice from Invasive Aspergillosis , 1995 .

[224]  David John Adams,et al.  Chitinase activity in human serum and leukocytes , 1995, Infection and immunity.

[225]  M. Ovejero,et al.  An immunodominant 90-kilodalton Aspergillus fumigatus antigen is the subunit of a catalase , 1995, Infection and immunity.

[226]  M. Richardson,et al.  Air sampling for aspergillus spp. during building activity in a paediatric hospital ward. , 1995, The Journal of hospital infection.

[227]  S. Kohno,et al.  Plasma (1-->3)-beta-D-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis , 1995, Journal of clinical microbiology.

[228]  J. Latgé,et al.  Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for hematological malignancies , 1995, Journal of clinical microbiology.

[229]  T. Larsen,et al.  Limited toxicity of prolonged therapy with high doses of amphotericin B lipid complex. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[230]  N. Müller,et al.  Acute lung disease in the immunocompromised host. Diagnostic accuracy of the chest radiograph. , 1995, Chest.

[231]  A. Casadevall,et al.  Antibody immunity and invasive fungal infections , 1995, Infection and immunity.

[232]  J. Varga,et al.  Phenotypic and genotypic analysis of variability in Aspergillus fumigatus , 1995, Journal of clinical microbiology.

[233]  T. Meshulam,et al.  A simplified new assay for assessment of fungal cell damage with the tetrazolium dye, (2,3)-bis-(2-methoxy-4-nitro-5-sulphenyl)-(2H)-tetrazolium-5-carboxanil ide (XTT). , 1995, The Journal of infectious diseases.

[234]  S. Chanock,et al.  Effects of macrophage colony-stimulating factor on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. , 1995, The Journal of infectious diseases.

[235]  P. Kolattukudy,et al.  Molecular cloning of the cDNA and gene for an elastinolytic aspartic proteinase from Aspergillus fumigatus and evidence of its secretion by the fungus during invasion of the host lung , 1995, Infection and immunity.

[236]  A. Niimi,et al.  Aspergillus culture filtrates and sputum sols from patients with pulmonary aspergillosis cause damage to human respiratory ciliated epithelium in vitro. , 1995, The European respiratory journal.

[237]  M. Ovejero,et al.  Aspergillus fumigatus antigens. , 1995, Microbiology.

[238]  T. Walsh,et al.  Pathogenesis of pulmonary aspergillosis. Granulocytopenia versus cyclosporine and methylprednisolone-induced immunosuppression. , 1995, American journal of respiratory and critical care medicine.

[239]  R. Amitani,et al.  Purification and characterization of factors produced by Aspergillus fumigatus which affect human ciliated respiratory epithelium , 1995, Infection and immunity.

[240]  H. Prentice,et al.  Host defence defects and possible approaches to their correction in the bone-marrow transplant recipient , 1995 .

[241]  T. Rogers Epidemiology and control of nosocomial fungal infections , 1995 .

[242]  P. Lui,et al.  Subtypes of Guanine-Nucleotide-Binding Regulatory Proteins at the Locus coeruleus Involved in Fentanyl-Induced Muscular Rigidity in the Rat. , 1995, Journal of biomedical science.

[243]  J. Bouchara,et al.  Cell surface properties of Aspergillus fumigatus conidia: correlation between adherence, agglutination, and rearrangements of the cell wall. , 1995, Canadian journal of microbiology.

[244]  U. Reichard,et al.  Molecular cloning and sequencing of the gene encoding an extracellular aspartic proteinase from Aspergillus fumigatus. , 1995, FEMS microbiology letters.

[245]  E. Anaissie,et al.  Protection of human polymorphonuclear leukocyte function from the deleterious effects of isolation, irradiation, and storage by interferon‐γ and granulocyte‐colony‐stimulating factor , 1995, Transfusion.

[246]  R. Crameri,et al.  Different reactivity to recombinant Aspergillus fumigatus allergen I/a in patients with atopic dermatitis or allergic asthma sensitised to Aspergillus fumigatus. , 1995, International archives of allergy and immunology.

[247]  J. Meis,et al.  Sandwich enzyme-linked immunosorbent assay compared with Pastorex latex agglutination test for diagnosing invasive aspergillosis in immunocompromised patients , 1995, Journal of clinical microbiology.

[248]  B. Hamory,et al.  Comparison of three typing methods for clinical and environmental isolates of Aspergillus fumigatus , 1995, Journal of clinical microbiology.

[249]  T. Patterson,et al.  Aspergillus antigen detection in the diagnosis of invasive aspergillosis. , 1995, The Journal of infectious diseases.

[250]  R. Hay,et al.  Purification, N-terminal amino acid sequence and partial characterization of a Cu,Zn superoxide dismutase from the pathogenic fungus Aspergillus fumigatus. , 1995, Free radical research.

[251]  L. Boulet,et al.  Increased expression of intercellular adhesion molecule‐1 (ICAM‐1) in a murine model of pulmonary eosinophilia and high IgE level , 1995, Clinical and experimental immunology.

[252]  M. Vidaud,et al.  Detection of Aspergillus species DNA in bronchoalveolar lavage samples by competitive PCR , 1995, Journal of clinical microbiology.

[253]  E. Michaliszyn,et al.  Lack of involvement of nitric oxide in killing of Aspergillus fumigatus conidia by pulmonary alveolar macrophages , 1995, Infection and immunity.

[254]  W. Coakley,et al.  Highly sensitive detection of fungal antigens by ultrasound-enhanced latex agglutination. , 1995, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[255]  M. Chapman,et al.  Antibody responses to Aspergillus fumigatus allergens in patients with cystic fibrosis. , 1995, International archives of allergy and immunology.

[256]  J. Latgé,et al.  Molecular characterization of the food-borne fungus Neosartorya fischeri (Malloch and Cain) , 1995, Applied and environmental microbiology.

[257]  P. Ambroise‐Thomas,et al.  Specific antibody detection in invasive aspergillosis by analytical isoelectrofocusing and immunoblotting methods , 1995, Journal of clinical microbiology.

[258]  B. Polla,,et al.  Serological evidence of Aspergillus type I hypersensitivity in a subgroup of pulmonary aspergilloma patients. , 1995, International archives of allergy and immunology.

[259]  M. Richardson,et al.  Stimulation of neutrophil phagocytosis of Aspergillus fumigatus conidia by interleukin-8 and N-formylmethionyl-leucylphenylalanine. , 1995, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[260]  J. Latgé,et al.  A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis , 1995, Journal of clinical microbiology.

[261]  R. Hay,et al.  Specific recognition of purified Cu,Zn superoxide dismutase from Aspergillus fumigatus by immune human sera , 1995, Journal of clinical microbiology.

[262]  K. Loudon,et al.  "Pseudoclusters" and typing by random amplification of polymorphic DNA of Aspergillus fumigatus. , 1995, Journal of clinical pathology.

[263]  J. Tobias,et al.  Antibiotic-based selection for bacterial genes that are specifically induced during infection of a host. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[264]  S. Kohno,et al.  Plasma (1→3)-β-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes , 1995, The Lancet.

[265]  J. Latgé Tools and trends in the detection of Aspergillus fumigatus. , 1995, Current topics in medical mycology.

[266]  K. Yanagihara,et al.  Detection of (1–3)‐β‐D‐glucan in a rat model of aspergillosis , 1995 .

[267]  J. Haines Aspergillus in compost: Straw man or fatal flaw? , 1995 .

[268]  J. Latgé,et al.  Antigens of Aspergillus fumigatus produced in vivo. , 1995, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[269]  R. Patterson,et al.  Allergic bronchopulmonary aspergillosis: serologic update for 1995. , 1995, Journal of clinical & laboratory immunology.

[270]  J. Latgé,et al.  Serologic monitoring of disease and treatment in a patient with pulmonary aspergilloma. , 1995, American journal of respiratory and critical care medicine.

[271]  D. Denning Issues in the management of invasive aspergillosis. , 1995, Annales de medecine interne.

[272]  L. Litzky,et al.  Rapid method for detection of Aspergillus 5S ribosomal RNA using a genus-specific oligonucleotide probe. , 1995, American journal of clinical pathology.

[273]  O. Lortholary,et al.  [Extra-pulmonary manifestations of invasive aspergillosis]. , 1995, Annales de medecine interne.

[274]  J. van de Loo,et al.  Pulmonary aspergillosis: early diagnosis improves survival. , 1995, Respiration; international review of thoracic diseases.

[275]  T. Sirakova,et al.  Cloning and characterization of the cDNAs and genes (mep20) encoding homologous metalloproteinases from Aspergillus flavus and A. fumigatus. , 1995, Gene.

[276]  P. Germaud,et al.  [The aspergillotic lung: radiological aspects]. , 1995, Annales de medecine interne.

[277]  W. Melchers,et al.  Polymerase chain reaction as a diagnostic tool for invasive aspergillosis: evaluation in bronchoalveolar lavage fluid from low risk patients , 1994 .

[278]  J. Latgé,et al.  Cloning and disruption of the gene encoding an extracellular metalloprotease of Aspergillus fumigatus , 1994, Molecular microbiology.

[279]  P. Beatty,et al.  The prophylactic use of low-dose amphotericin B in bone marrow transplant patients. , 1994, The American journal of medicine.

[280]  J. Pitt The current role of Aspergillus and Penicillium in human and animal health. , 1994, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[281]  G. V. van Steijn,et al.  Partial purification and further characterization of the novel endoglucosaminidase from human serum that hydrolyses 4-methylumbelliferyl-N-acetyl-beta-D-chitotetraoside (MU-TACT hydrolase). , 1994, The International journal of biochemistry.

[282]  T. Walsh,et al.  In vitro and ex vivo effects of cyclosporin A on phagocytic host defenses against Aspergillus fumigatus , 1994, Antimicrobial Agents and Chemotherapy.

[283]  J. Latgé,et al.  Chemical and immunological characterization of the extracellular galactomannan of Aspergillus fumigatus , 1994, Infection and immunity.

[284]  C. Tang,et al.  Virulence of Aspergillus fumigatus double mutants lacking restriction and an alkaline protease in a low-dose model of invasive pulmonary aspergillosis , 1994, Infection and immunity.

[285]  C. Tang,et al.  Virulence studies of Aspergillus nidulans mutants requiring lysine or p-aminobenzoic acid in invasive pulmonary aspergillosis , 1994, Infection and immunity.

[286]  N. Müller,et al.  Invasive aspergillosis of the airways: radiographic, CT, and pathologic findings. , 1994, Radiology.

[287]  Hongyung Choi,et al.  IgE and eosinophil regulation in a murine model of allergic aspergillosis , 1994, Journal of leukocyte biology.

[288]  U. Reichard,et al.  Purification and characterization of an extracellular aspartic proteinase from Aspergillus fumigatus. , 1994, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[289]  K. Kwon-Chung,et al.  HYP1, a hydrophobin gene from Aspergillus fumigatus, complements the rodletless phenotype in Aspergillus nidulans , 1994, Infection and immunity.

[290]  R. Braun,et al.  Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. , 1994, American journal of respiratory and critical care medicine.

[291]  J. Latgé,et al.  rodletless mutants of Aspergillus fumigatus , 1994, Infection and immunity.

[292]  D. Venzon,et al.  Antifungal activity of elutriated human monocytes against Aspergillus fumigatus hyphae: enhancement by granulocyte-macrophage colony-stimulating factor and interferon-gamma. , 1994, The Journal of infectious diseases.

[293]  J. Bolard,et al.  The endocytic process in CHO cells, a toxic pathway of the polyene antibiotic amphotericin B , 1994, Antimicrobial Agents and Chemotherapy.

[294]  T. Sirakova,et al.  Molecular cloning and sequencing of the cDNA and gene for a novel elastinolytic metalloproteinase from Aspergillus fumigatus and its expression in Escherichia coli , 1994, Infection and immunity.

[295]  H. Sakagami,et al.  Cloning and nucleotide sequence of cDNA encoding Asp-hemolysin from Aspergillus fumigatus. , 1994, Biochimica et biophysica acta.

[296]  E. Gluckman,et al.  [Invasive aspergillosis and bone marrow allograft]. , 1994, Pathologie-biologie.

[297]  N. Nolard [Links between risks of aspergillosis and environmental contamination. Review of the literature]. , 1994, Pathologie-biologie.

[298]  B. Dupont [Curative treatment of invasive aspergillosis]. , 1994, Pathologie-biologie.

[299]  G. Robson,et al.  Hydrocortisone-enhanced growth of Aspergillus spp.: implications for pathogenesis. , 1994, Microbiology.

[300]  B. Lebeau,et al.  [Invasive aspergillosis: management of mycological diagnosis]. , 1994, Pathologie-biologie.

[301]  J. van de Loo,et al.  Pulmonary fungal infections in immunocompromised patients: incidence and risk factors , 1994, Mycoses.

[302]  A. Levine,et al.  Asp f I CD4+ TH2-like T-cell lines in allergic bronchopulmonary aspergillosis. , 1994, The Journal of allergy and clinical immunology.

[303]  J. Perfect,et al.  NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis. , 1994, The American journal of medicine.

[304]  M. Schlaak,et al.  Analysis of IgG subclass and IgE response in allergic disease caused by Aspergillus fumigatus by immunoblotting techniques. , 1994, International archives of allergy and immunology.

[305]  A. van Belkum,et al.  General primer-mediated PCR for detection of Aspergillus species , 1994, Journal of clinical microbiology.

[306]  P. Kolattukudy,et al.  Purification and characterization of an elastinolytic metalloprotease from Aspergillus fumigatus and immunoelectron microscopic evidence of secretion of this enzyme by the fungus invading the murine lung , 1994, Infection and immunity.

[307]  J. Bouchara,et al.  Specific interaction of Aspergillus fumigatus with fibrinogen and its role in cell adhesion , 1994, Infection and immunity.

[308]  Hongyung Choi,et al.  Particulate Aspergillus fumigatus antigens elicit a TH2 response in BALB/c mice. , 1994, The Journal of allergy and clinical immunology.

[309]  V. Kurup,et al.  Aspergillus ribotoxins react with IgE and IgG antibodies of patients with allergic bronchopulmonary aspergillosis. , 1994, The Journal of laboratory and clinical medicine.

[310]  R. Slavin,et al.  Serum anti-Aspergillus fumigatus antibodies by immunoblot and ELISA in cystic fibrosis with allergic bronchopulmonary aspergillosis. , 1994, The Journal of allergy and clinical immunology.

[311]  R. Reporter,et al.  Investigation of an epidemic of invasive aspergillosis: utility of molecular typing with the use of random amplified polymorphic DNA probes. , 1994, The Pediatric infectious disease journal.

[312]  W. Siegert,et al.  Strategies in prevention of invasive pulmonary aspergillosis in immunosuppressed or neutropenic patients , 1994, Antimicrobial Agents and Chemotherapy.

[313]  S. Kelly,et al.  Microbial transformations of steroids—VIII. Transformation of progesterone by whole cells and microsomes of Aspergillus fumigatus , 1994, The Journal of Steroid Biochemistry and Molecular Biology.

[314]  J. A. Liu Yin,et al.  Invasive aspergillosis: clusters and sources? , 1994, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[315]  S. Hinrichs,et al.  Airborne Fungal Spore Monitoring in a Protective Environment During Hospital Construction, and Correlation with an Outbreak of Invasive Aspergillosis , 1994, Infection Control & Hospital Epidemiology.

[316]  N. Georgopapadakou,et al.  Human mycoses: drugs and targets for emerging pathogens. , 1994, Science.

[317]  A. Müllbacher,et al.  In vivo immunosuppressive activity of gliotoxin, a metabolite produced by human pathogenic fungi , 1994, Infection and immunity.

[318]  J. Niland,et al.  Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[319]  R. Crameri,et al.  Recombinant expression and antigenic properties of a 32-kilodalton extracellular alkaline protease, representing a possible virulence factor from Aspergillus fumigatus , 1994, Infection and immunity.

[320]  J. Latgé,et al.  Use of DNA moderately repetitive sequence to type Aspergillus fumigatus isolates from aspergilloma patients. , 1994, The Journal of infectious diseases.

[321]  T. Walsh,et al.  Dose-dependent antifungal activity and nephrotoxicity of amphotericin B colloidal dispersion in experimental pulmonary aspergillosis , 1994, Antimicrobial Agents and Chemotherapy.

[322]  J. Latgé,et al.  Molecular epidemiology of nosocomial invasive aspergillosis , 1994, Journal of clinical microbiology.

[323]  J. Shelhamer,et al.  Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: the potential role of bronchoalveolar D-mannitol and serum galactomannan as markers of infection. , 1994, The Journal of infectious diseases.

[324]  O. Ringdén,et al.  High cure rate of invasive fungal infections in immunocompromised children using ambisome. , 1994, Transplantation proceedings.

[325]  M. Denis,et al.  Experimental Allergic Bronchopulmonary Aspergillosis in the Mouse: Immunological and Histological Features , 1994, Scandinavian journal of immunology.

[326]  J. Latgé,et al.  Exoantigens of Aspergillus Fumigatus: Serodiagnosis and Virulence , 1994 .

[327]  J. Varga,et al.  Application of RFLPs in Systematics and Population Genetics of Aspergilli , 1994 .

[328]  P. Mischnick,et al.  Application of reductive cleavage in the structural investigation of the antigenic polysaccharides of Aspergillus fumigatus and Penicillium digitatum with respect to the determination of the ring size of the galactose moieties , 1994 .

[329]  R. Hoekstra,et al.  PHYSICAL KARYOTYPING GENETIC AND TAXONOMIC APPLICATIONS IN ASPERGILLI , 1994 .

[330]  R. Samson Current Systematics of the Genus Aspergillus , 1994 .

[331]  L. Brochard,et al.  Bronchoalveolar lavage during neutropenic episodes: diagnostic yield and cellular pattern. , 1994, The European respiratory journal.

[332]  J. Burnie,et al.  Epitope mapping human heat shock protein 90 with sera from infected patients. , 1994, FEMS immunology and medical microbiology.

[333]  R. Hay,et al.  Environmental sampling for aspergilli during building construction on a hospital site. , 1994, The Journal of hospital infection.

[334]  B. Kullberg,et al.  Cytokines in the treatment of fungal infections , 1994, Biotherapy.

[335]  G. Menz,et al.  Diagnostic value of recombinant Aspergillus fumigatus allergen I/a for skin testing and serology. , 1994, The Journal of allergy and clinical immunology.

[336]  A. Schaffner Macrophage-Aspergillus interactions. , 1994, Immunology series.

[337]  A. Spock,et al.  Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. , 1994, Chest.

[338]  David Holden,et al.  Detection of Aspergillus fumigatus by Polymerase Chain Reaction , 1994, Journal of clinical microbiology.

[339]  I. Adcock,et al.  Anti-inflammatory actions of steroids: molecular mechanisms. , 1993, Trends in pharmacological sciences.

[340]  P. Moreau,et al.  Localized invasive pulmonary aspergillosis in patients with neutropenia. Effectiveness of surgical resection , 1993, Cancer.

[341]  J. Latgé,et al.  Application of a lowicryl K4M embedding technique for analysis of fungal adhesins , 1993 .

[342]  D. Venzon,et al.  Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon , 1993, Infection and immunity.

[343]  M. Prevost,et al.  Identification of the 33-kDa alkaline protease of Aspergillus fumigatus in vitro and in vivo. , 1993, Journal of medical microbiology.

[344]  T. Walsh,et al.  Prevention of invasive fungal infections in patients with neoplastic disease. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[345]  V. Andriole Infections with Aspergillus species. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[346]  M. Rinaldi,et al.  Efficacy of itraconazole solution in a rabbit model of invasive aspergillosis , 1993, Antimicrobial Agents and Chemotherapy.

[347]  J. Sawada,et al.  Isolation and characterization of a major allergenic component (gp55) of Aspergillus fumigatus. , 1993, The Journal of allergy and clinical immunology.

[348]  C. Tang,et al.  The detection of Aspergillus spp. by the polymerase chain reaction and its evaluation in bronchoalveolar lavage fluid. , 1993, The American review of respiratory disease.

[349]  R. Barnes Aspergillus infection: does serodiagnosis work? , 1993 .

[350]  E. Anaissie,et al.  Role of granulocyte-macrophage colony-stimulating factor as adjuvant therapy for fungal infection in patients with cancer. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[351]  D. Stevens,et al.  Discrepancies in bioassay and chromatography determinations explained by metabolism of itraconazole to hydroxyitraconazole: studies of interpatient variations in concentrations , 1993, Antimicrobial Agents and Chemotherapy.

[352]  J. Warner,et al.  Optimized preparation of Aspergillus fumigatus extracts for allergy diagnosis , 1993, Clinical and Experimental Allergy.

[353]  J. Latgé,et al.  Isolation and characterization of a secreted metalloprotease of Aspergillus fumigatus , 1993, Infection and immunity.

[354]  E. Michaliszyn,et al.  Acquired immunity in experimental murine aspergillosis is mediated by macrophages , 1993, Infection and immunity.

[355]  C. Richard,et al.  Invasive pulmonary aspergillosis prior to BMT in acute leukemia patients does not predict a poor outcome. , 1993, Bone marrow transplantation.

[356]  H. Prentice,et al.  Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[357]  C. Kemper,et al.  Ulcerative and plaque-like tracheobronchitis due to infection with Aspergillus in patients with AIDS. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[358]  M. Denis,et al.  Cyclosporin A increases the pulmonary eosinophilia induced by inhaled Aspergillus antigen in mice , 1993, Clinical and experimental immunology.

[359]  J. Davies,et al.  Construction and pathogenicity of Aspergillus fumigatus mutants that do not produce the ribotoxin restrictocin , 1993, Molecular microbiology.

[360]  W. Quint,et al.  Typing of Aspergillus species and Aspergillus fumigatus isolates by interrepeat polymerase chain reaction , 1993, Journal of clinical microbiology.

[361]  J. Nikoskelainen,et al.  Lethal infections in patients with hematological malignancies , 1993, European journal of haematology.

[362]  O. Lortholary,et al.  Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. French Cooperative Study Group on Aspergillosis in AIDS. , 1993, The American journal of medicine.

[363]  F. Derouin,et al.  Epidemiology and diagnosis of invasive pulmonary aspergillosis in bone marrow transplant patients: results of a 5 year retrospective study. , 1993, Bone marrow transplantation.

[364]  J. Latgé,et al.  A transformant of Aspergillus fumigatus deficient in the antigenic cytotoxin ASPFI. , 1993, FEMS microbiology letters.

[365]  D. Stynen,et al.  Effect of tissue invasion and treatment with itraconazole or amphotericin B on galactomannan levels in plasma of guinea-pigs with experimental invasive aspergillosis , 1993 .

[366]  N. Nolard,et al.  Typing by irnrnunoblot of Aspergillus fumigatus from nosocornial infections , 1993, Mycoses.

[367]  A. Venot,et al.  Prognostic factors of invasive pulmonary aspergillosis in leukemic patients. , 1993, Leukemia & lymphoma.

[368]  S. Hetherington,et al.  Complement binding to Aspergillus conidia correlates with pathogenicity. , 1993, The Journal of laboratory and clinical medicine.

[369]  D. Irwin,et al.  Isogenic strain construction and gene mapping in Candida albicans. , 1993, Genetics.

[370]  L. Rogers,et al.  Evidence for possible involvement of an elastolytic serine protease in aspergillosis , 1993, Infection and immunity.

[371]  J. Latgé,et al.  Development of DNA probes for fingerprinting Aspergillus fumigatus , 1993, Journal of clinical microbiology.

[372]  D. Huhn,et al.  Aerosol amphotericin B for prevention of invasive pulmonary aspergillosis , 1993, Antimicrobial Agents and Chemotherapy.

[373]  T. Klein,et al.  Granulocyte colony-stimulating factor potentiates anti-Candida albicans growth inhibitory activity of polymorphonuclear cells. , 1993, FEMS immunology and medical microbiology.

[374]  Y. Sato,et al.  Combined anti-fungal therapy and surgical resection as treatment of disseminated aspergillosis of the lung and brain following BMT. , 1993, Bone marrow transplantation.

[375]  V. Kurup,et al.  Isolation and characterization of a recombinant heat shock protein of Aspergillus fumigatus. , 1993, The Journal of allergy and clinical immunology.

[376]  J. Burnie,et al.  Application of polymerase chain reaction to fingerprinting Aspergillus fumigatus by random amplification of polymorphic DNA , 1993, Journal of clinical microbiology.

[377]  C. Beck-Sague,et al.  Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. , 1993, The Journal of infectious diseases.

[378]  C. Tang,et al.  The alkaline protease of Aspergillus fumigatus is not a virulence determinant in two murine models of invasive pulmonary aspergillosis , 1993, Infection and immunity.

[379]  K. Uhlig,et al.  Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon , 1993, Infection and immunity.

[380]  V. Kurup,et al.  Specific amplification of Aspergillus fumigatus DNA by polymerase chain reaction. , 1993, Molecular and cellular probes.

[381]  H. Schønheyder,et al.  Experimental murine mycotic placentitis and abortion. A potent animal model (short communication). , 1993, Journal of experimental animal science.

[382]  J. Wessels Tansley Review No. 45 Wall growth, protein excretion and morphogenesis in fungi. , 1993, The New phytologist.

[383]  J. Armitage,et al.  Nosocomial Invasive Aspergillosis in Lymphoma Patients Treated with Bone Marrow or Peripheral Stem Cell Transplants , 1993, Infection Control & Hospital Epidemiology.

[384]  V. Kurup,et al.  Production and characterization of a monoclonal antibody to a major concanavalin A--nonbinding antigen of Aspergillus fumigatus. , 1993, The Journal of laboratory and clinical medicine.

[385]  Hongyung Choi,et al.  Aspergillus fumigatus antigen Induced eosinophilia in mice is abrogated by anti‐IL‐5 antibody , 1993, Journal of leukocyte biology.

[386]  G. Lopez-Berestein,et al.  Roles of liposome composition and temperature in distribution of amphotericin B in serum lipoproteins , 1993, Antimicrobial Agents and Chemotherapy.

[387]  J. Latgé,et al.  Detection of galactomannan and the 18 kDa antigen from Aspergillus fumigatus in serum and urine from cattle with systemic aspergillosis. , 1993, Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B.

[388]  J. Latgé,et al.  An 88-kilodalton antigen secreted by Aspergillus fumigatus , 1991, Infection and Immunity.

[389]  L. L. Smith,et al.  Allergic bronchopulmonary aspergillosis in patients with and without evidence of bronchiectasis. , 1993, Annals of allergy.

[390]  J. Latgé,et al.  Virulence of alkaline protease-deficient mutants of Aspergillus fumigatus. , 1993, FEMS microbiology letters.

[391]  J. Lissitzky,et al.  Interaction between Aspergillus fumigatus and basement membrane laminin: Binding and substrate degradation , 1993, Biology of the cell.

[392]  M. Cuevas,et al.  IgG subclass response to Aspergillus fumigatus. , 1993, International archives of allergy and immunology.

[393]  A. Nagler,et al.  Invasive fungal sinusitis in patients undergoing bone marrow transplantation. , 1993, Bone marrow transplantation.

[394]  A. Wardlaw,et al.  Allergie Bronchopulmonary Aspergillosis: A Review , 1992, Journal of the Royal Society of Medicine.

[395]  D. Denning,et al.  Lack of vessel wall elastolysis in human invasive pulmonary aspergillosis , 1992, Infection and immunity.

[396]  M. Chapman,et al.  Selective expression of a major allergen and cytotoxin, Asp f I, in Aspergillus fumigatus. Implications for the immunopathogenesis of Aspergillus-related diseases. , 1992, Journal of immunology.

[397]  P. Legrand,et al.  Effects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytes , 1992, Antimicrobial Agents and Chemotherapy.

[398]  D. Holden,et al.  Use of randomly amplified polymorphic DNA markers to distinguish isolates of Aspergillus fumigatus , 1992, Journal of clinical microbiology.

[399]  C. Virchow,et al.  Specific serum immunopatterns in clinical phases of allergic bronchopulmonary aspergillosis. , 1992, The Journal of allergy and clinical immunology.

[400]  F. Rombouts,et al.  New structural features of the antigenic extracellular polysaccharides of Penicillium and Aspergillus species revealed with exo-beta-D-galactofuranosidase , 1992, Journal of bacteriology.

[401]  J. Latgé,et al.  Participation of complement in the phagocytosis of the conidia of Aspergillus fumigatus by human polymorphonuclear cells. , 1992, The Journal of infectious diseases.

[402]  R. Slavin,et al.  Allergic bronchopulmonary mycosis complicating cystic fibrosis. , 1992, Seminars in respiratory infections.

[403]  S. Banerjee,et al.  Fungal infections of the small and large intestine. , 1992, Journal of clinical pathology.

[404]  W. Kenealy,et al.  Effects of amino-terminal extensions and specific mutations on the activity of restrictocin. , 1992, The Journal of biological chemistry.

[405]  J. Sugiyama,et al.  Application of ubiquinone systems and electrophoretic comparison of enzymes to identification of clinical isolates of Aspergillus fumigatus and several other species of Aspergillus , 1992, Journal of clinical microbiology.

[406]  M. Gmachl,et al.  Cloning and expression of recombinant Aspergillus fumigatus allergen I/a (rAsp f I/a) with IgE binding and type I skin test activity. , 1992, Journal of immunology.

[407]  S. Peterson Neosartorya pseudofischeri sp. nov. and its relationship to other species in Aspergillus section Fumigati , 1992 .

[408]  H. Tamura,et al.  Determination of plasma (1 → 3)-β-d-glucan: A new diagnostic aid to deep mycosis , 1992 .

[409]  H. Yamaguchi,et al.  Granulocyte-colony stimulating factor facilitates the restoration of resistance to opportunistic fungi in leukopenic mice. , 1992, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[410]  Hongyung Choi,et al.  A murine model of allergic bronchopulmonary aspergillosis with elevated eosinophils and IgE. , 1992, Journal of immunology.

[411]  Dirk,et al.  Rat monoclonal antibodies against Aspergillus galactomannan , 1992, Infection and immunity.

[412]  H. Magnussen,et al.  [Invasive aspergillosis in cavitary lung sarcoidosis]. , 1992, Pneumologie.

[413]  C. Tang,et al.  An Aspergillus fumigatus alkaline protease mutant constructed by gene disruption is deficient in extracellular elastase activity , 1992, Molecular microbiology.

[414]  M. Chapman,et al.  Aspergillus fumigatus: identification of 16, 18, and 45 kd antigens recognized by human IgG and IgE antibodies and murine monoclonal antibodies. , 1992, The Journal of allergy and clinical immunology.

[415]  J. Latgé,et al.  Interactions between conidia of Aspergillus fumigatus and human complement component C3 , 1992, Infection and immunity.

[416]  S. Forman,et al.  The value of bronchoalveolar lavage and bronchial washings in the diagnosis of invasive pulmonary aspergillosis. , 1992, Respiratory medicine.

[417]  V. Kurup,et al.  Monoclonal antibodies bind identically to both spores and hyphae of Aspergillus fumigatus , 1992, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[418]  J. Bouchara,et al.  Specific binding of human fibrinogen fragment D to Aspergillus fumigatus conidia , 1992, Infection and immunity.

[419]  R. Falchetto,et al.  Nucleotide sequence of a genomic and a cDNA clone encoding an extracellular alkaline protease of Aspergillus fumigatus. , 1992, FEMS microbiology letters.

[420]  J. Burnie,et al.  Restriction endonuclease analysis of Aspergillus fumigatus DNA. , 1992, Journal of clinical pathology.

[421]  J. Visser,et al.  University of Groningen Localization of Glucose Oxidase and Catalase Activities in Aspergillus niger , 2017 .

[422]  J. D. Macmillan,et al.  Inhibition of Aspergillus fumigatus elastase with monoclonal antibodies produced by using denatured elastase as an immunogen , 1992, Infection and immunity.

[423]  T. Patterson,et al.  Animal models: usefulness for studies of fungal pathogenesis and drug efficacy in aspergillosis. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[424]  J. D. Macmillan,et al.  Purification and properties of the elastase from Aspergillus fumigatus , 1992, Infection and Immunity.

[425]  A. Strosberg,et al.  A Monoclonal Antibody Specific for Conidia and Mycelium Wall Layer of Penicillium and Aspergillus , 1992, Microbiology and immunology.

[426]  S. Steinberg,et al.  Patterns of Infection in Patients with Aplastic Anemia and the Emergence of Aspergillus As a Major Cause of Death , 1992, Medicine.

[427]  Hearn Vm Antigenicity of Aspergillus species , 1992 .

[428]  V. Hearn Antigenicity of Aspergillus species. , 1992, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[429]  D. Denning,et al.  In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents. , 1992, Diagnostic microbiology and infectious disease.

[430]  R. Walesby,et al.  Surgical management of invasive pulmonary aspergillosis in immunocompromised patients. , 1992, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[431]  E. Wilson,et al.  Analysis of Aspergillus fumigatus catalases possessing antigenic activity. , 1992, Journal of Medical Microbiology.

[432]  M. Ovejero,et al.  Analysis of Aspergillus nidulans conidial antigens and their prevalence in other Aspergillus species , 1991, Infection and immunity.

[433]  M. Gottlieb,et al.  Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation. , 1991, The American journal of medicine.

[434]  P. Arnow,et al.  Endemic and epidemic aspergillosis associated with in-hospital replication of Aspergillus organisms. , 1991, The Journal of infectious diseases.

[435]  V. Kurup,et al.  Immunodiagnosis of aspergillosis , 1991, Clinical Microbiology Reviews.

[436]  J. Burnie,et al.  Heat shock protein 88 and Aspergillus infection , 1991, Journal of clinical microbiology.

[437]  D. Mackenzie,et al.  Serodiagnosis of Aspergillosis , 1991 .

[438]  R. Gaynes,et al.  Major trends in the microbial etiology of nosocomial infection. , 1991, The American journal of medicine.

[439]  R. Slavin,et al.  Variability in parameters of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. , 1991, The Journal of allergy and clinical immunology.

[440]  D. Denning,et al.  Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole. , 1991, Chest.

[441]  M. Prevost,et al.  The 18-kilodalton antigen secreted by Aspergillus fumigatus , 1991, Infection and immunity.

[442]  D. Armstrong,et al.  Combination therapy in a model of pulmonary aspergillosis , 1991, Mycoses.

[443]  O. Zetterström,et al.  Aspergillus fumigatus specific IgE and IgG antibodies for diagnosis of Aspergillus‐related lung diseases , 1991, Allergy.

[444]  J. Latgé,et al.  Secretion of a potential virulence factor, a fungal ribonucleotoxin, during human aspergillosis infections , 1991, Molecular microbiology.

[445]  D. Armstrong,et al.  Model of recurrent pulmonary aspergillosis in rats , 1991, Journal of clinical microbiology.

[446]  L. Rahalison,et al.  Isolation and characterisation of an extracellular alkaline protease of Aspergillus fumigatus. , 1991, Journal of medical microbiology.

[447]  J. Warner,et al.  Aspergillus allergy and allergic bronchopulmonary aspergillosis in cystic fibrosis , 1991 .

[448]  L. Pedneault,et al.  Immunoblot analyses of the serologic response to Aspergillus fumigatus antigens in experimental invasive aspergillosis. , 1991, The Journal of infectious diseases.

[449]  F. Rhame,et al.  Prevention of nosocomial aspergillosis. , 1991, The Journal of hospital infection.

[450]  M. Schousboe,et al.  Intranasal amphotericin B reduces the frequency of invasive aspergillosis in neutropenic patients. , 1991, The American journal of medicine.

[451]  V. Kurup,et al.  Characterization of a monoclonal antibody against concanavalin A binding antigen of Aspergillus fumigatus. , 1991, Hybridoma.

[452]  D. Adams,et al.  10 year review of invasive aspergillosis detected at necropsy. , 1991, Journal of clinical pathology.

[453]  A. Polak‐Wyss,et al.  Protective effect of human granulocyte colony‐stimulating factor (hG‐CSF) on Cryptococcus and Aspergillus infections in normal and immunosuppressed mice , 1991, Mycoses.

[454]  J. Bennett,et al.  Beta 1,4-oligoglucosides inhibit the binding of Aspergillus fumigatus conidia to human monocytes. , 1991, The Journal of infectious diseases.

[455]  H. Malech,et al.  In vivo interferon-gamma therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae. , 1991, The Journal of infectious diseases.

[456]  J. Clark,et al.  Amphotericin B lipid complex therapy of experimental fungal infections in mice , 1991, Antimicrobial Agents and Chemotherapy.

[457]  B. Lamy,et al.  Isolation and nucleotide sequence of the Aspergillus restrictus gene coding for the ribonucleolytic toxin restrictocin and its expression in Aspergillus nidulans: the leader sequence protects producing strains from suicide. , 1991, Nucleic acids research.

[458]  D. Denning,et al.  Pulmonary aspergillosis in the acquired immunodeficiency syndrome. , 1991, The New England journal of medicine.

[459]  G. Shankland,et al.  Opsonizing activity of G‐reactive protein in phagocytosis of Aspergillus fumigatus conidia by human neutrophils , 1991, Mycoses.

[460]  T J Walsh,et al.  Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. , 1991, The Journal of infectious diseases.

[461]  B. Paulsen,et al.  Purification of a 20 kD allergen from Aspergillus fumigatus , 1991, Allergy.

[462]  A. Cumber,et al.  Biochemical, cytotoxic and pharmacokinetic properties of an immunotoxin composed of a mouse monoclonal antibody Fib75 and the ribosome-inactivating protein alpha-sarcin from Aspergillus giganteus. , 1991, European journal of biochemistry.

[463]  T. Mikami,et al.  Preparation and Purification of Monoclonal Antibodies for Aspergillus fumigatus , 1991 .

[464]  H. Buckley,et al.  Production and characterization of monoclonal antibodies to a 58-kilodalton antigen of Aspergillus fumigatus , 1991, Infection and immunity.

[465]  H. Buckley,et al.  Identification and characterization of an immunodominant 58-kilodalton antigen of Aspergillus fumigatus recognized by sera of patients with invasive aspergillosis , 1991, Infection and immunity.

[466]  M. J. Schiff,et al.  Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease. , 1991, Thorax.

[467]  P. Greenberger,et al.  The prevalence of allergic bronchopulmonary aspergillosis in patients with asthma, determined by serologic and radiologic criteria in patients at risk. , 1991, The Journal of laboratory and clinical medicine.

[468]  M. Prevost,et al.  Galactomannan and the Circulating Antigens of Aspergillus Fumigatus , 1991 .

[469]  J. Latgé,et al.  Complement and Phagocytosis in Aspergillus , 1991 .

[470]  F. Odds Potential for Penetration of Passive Barriers to Fungal Invasion in Humans , 1991 .

[471]  M. D. Robertson Suppression of Phagocytic Cell Responses by Conidia and Conidial Products of Aspergillus fumigatus , 1991 .

[472]  R. Powles,et al.  The prophylaxis of fungal infections. , 1991, The Journal of antimicrobial chemotherapy.

[473]  J. V. D. van der Meer,et al.  The efficacy of itraconazole against systemic fungal infections in neutropenic patients: a randomised comparative study with amphotericin B. , 1991, The Journal of infection.

[474]  John I. Gallin,et al.  A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. The International Chronic Granulomatous Disease Cooperative Study Group. , 1991, The New England journal of medicine.

[475]  H. C. Hoch,et al.  The Fungal Spore and Disease Initiation in Plants and Animals , 1991, Springer US.

[476]  S. Clissold,et al.  Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses. , 1990, Drugs.

[477]  U. Reichard,et al.  Purification and characterisation of an extracellular serine proteinase from Aspergillus fumigatus and its detection in tissue. , 1990, Journal of medical microbiology.

[478]  T. Rogers,et al.  Value of antigen detection in predicting invasive pulmonary aspergillosis , 1990, The Lancet.

[479]  J. Fox,et al.  Brief Definitive Report , 2022 .

[480]  D. Denning,et al.  Restriction endonuclease analysis of total cellular DNA of Aspergillus fumigatus isolates of geographically and epidemiologically diverse origin. , 1990, The Journal of infectious diseases.

[481]  D. Denning,et al.  Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. , 1990, Reviews of infectious diseases.

[482]  R. Washburn,et al.  Aspergillus fumigatus complement inhibitor: production, characterization, and purification by hydrophobic interaction and thin-layer chromatography , 1990, Infection and immunity.

[483]  B. Robinson,et al.  Allergens as proteases: an Aspergillus fumigatus proteinase directly induces human epithelial cell detachment. , 1990, The Journal of allergy and clinical immunology.

[484]  D. Armstrong,et al.  Aspergillus species from hospital air and from patients , 1990, Mycoses.

[485]  A. Pallett,et al.  Invasive aspergillosis in immunosuppressed patients: potential hazard of hospital building work. , 1990, BMJ.

[486]  B. Bainbridge,et al.  Restriction fragment length polymorphisms in isolates of Aspergillus fumigatus probed with part of the intergenic spacer region from the ribosomal RNA gene complex of Aspergillus nidulans. , 1990, Journal of general microbiology.

[487]  L. L. Smith,et al.  Immunoblot analysis of sera from patients with allergic bronchopulmonary aspergillosis: correlation with disease activity. , 1990, The Journal of allergy and clinical immunology.

[488]  B. Dupont Itraconazole therapy in aspergillosis: study in 49 patients. , 1990, Journal of the American Academy of Dermatology.

[489]  J. Latgé,et al.  Detection of Aspergillus antigens associated with invasive infection , 1990, Journal of clinical microbiology.

[490]  P. Waring DNA fragmentation induced in macrophages by gliotoxin does not require protein synthesis and is preceded by raised inositol triphosphate levels. , 1990, The Journal of biological chemistry.

[491]  J. Latgé,et al.  Immunochemical studies of Aspergillus fumigatus mycelial antigens by polyacrylamide gel electrophoresis and western blotting techniques. , 1990, Journal of general microbiology.

[492]  H. Malech,et al.  Normal and deficient neutrophils can cooperate to damage Aspergillus fumigatus hyphae. , 1990, The Journal of infectious diseases.

[493]  L. Pedneault,et al.  Production and characterization of monoclonal antibodies to cell wall antigens of Aspergillus fumigatus , 1990, Infection and immunity.

[494]  D. Armstrong,et al.  Use of immunoblotting to detect Aspergillus fumigatus antigen in sera and urines of rats with experimental invasive aspergillosis , 1990, Journal of clinical microbiology.

[495]  S. McCann,et al.  Nebulized amphotericin B as prophylaxis against invasive aspergillosis in granulocytopenic patients. , 1990, Bone marrow transplantation.

[496]  Peacock Je,et al.  Amphotericin B revisited: reassessment of toxicity. , 1990, The American journal of medicine.

[497]  K. Do,et al.  Interaction of Granulocytopenia and Construction Activity as Risk Factors for Nosocomial Invasive Filamentous Fungal Disease in Patients With Hematologic Disorders , 1990, Infection Control & Hospital Epidemiology.

[498]  M. Collins,et al.  Use of DBA/2N mice in models of systemic candidiasis and pulmonary and systemic aspergillosis , 1990, Infection and immunity.

[499]  P. Biddinger,et al.  Experimental murine invasive pulmonary aspergillosis. , 1990, American journal of clinical pathology.

[500]  V. Kurup,et al.  Antibody isotype responses in Aspergillus-induced diseases. , 1990, The Journal of laboratory and clinical medicine.

[501]  H. Gallis,et al.  Amphotericin B: 30 years of clinical experience. , 1990, Reviews of infectious diseases.

[502]  S. Levitz,et al.  Human Neutrophil Degranulation Stimulated by Aspergillus fumigatus , 1990, Journal of leukocyte biology.

[503]  J. Frisvad,et al.  Chemotaxonomy and Morphology of Aspergillus Fumigatus and Related Taxa , 1990 .

[504]  J. Peacock,et al.  Amphotericin B revisited: reassessment of toxicity. , 1990, The American journal of medicine.

[505]  J. Kalbfleisch,et al.  Immunopathological response of C57BL/6 and C3H/HeN mice to Aspergillus fumigatus antigens. , 1990, International archives of allergy and applied immunology.

[506]  V. Kurup,et al.  Isolation and immunochemical characterization of fractions from membranes of Aspergillus fumigatus with protease activity. , 1990, Canadian journal of microbiology.

[507]  J. Kalbfleisch,et al.  Detection of circulating Aspergillus fumigatus antigen in bone marrow transplant patients. , 1989, The Journal of laboratory and clinical medicine.

[508]  M. A. Wilson,et al.  Activation of C3 and binding to Aspergillus fumigatus conidia and hyphae , 1989, Infection and immunity.

[509]  G. Verhoef,et al.  Antifungal Prophylaxis with Itraconazole in Prolonged Neutropenia: Correlation with Plasma Levels , 1989, Mycoses.

[510]  A. Schaffner Experimental Basis for the Clinical Epidemiology of Fungal Infections. A Review: Die experimentelle Grundlage der Minischen Epidemiologie von Pilzinfektionen. Übersicht , 1989, Mycoses.

[511]  K. Yokota,et al.  Effect of Chemical Modification on the Hemolytic Activity of Asp-Hemolysin from Aspergillus fumigatus , 1989 .

[512]  K. Kerr,et al.  Killing of Aspergillus fumigatus spores by human lung macrophages: a paradoxical effect of heat-labile serum components. , 1989, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[513]  T. Rogers,et al.  Control of an outbreak of nosocomial aspergillosis by laminar air-flow isolation. , 1989, The Journal of hospital infection.

[514]  J. Bolard,et al.  The polyene antibiotic amphotericin B acts as a Ca2+ ionophore in sterol-containing liposomes. , 1989, Biochimica et biophysica acta.

[515]  R. M. Tucker,et al.  Treatment of invasive aspergillosis with itraconazole. , 1989, The American journal of medicine.

[516]  P. Phillips,et al.  Antigenemia in a rabbit model of invasive aspergillosis. , 1989, The Journal of infectious diseases.

[517]  F. Mandelli,et al.  Aspergillus colonization of the nose and pulmonary aspergillosis in neutropenic patients: a retrospective study. , 1989, Haematologica.

[518]  T. Walsh,et al.  Fungus dose-dependent primary pulmonary aspergillosis in immunosuppressed mice , 1989, Infection and immunity.

[519]  G. Menz,et al.  Immunoprint pattern in patients with allergic bronchopulmonary aspergillosis in different stages. , 1989, The Journal of allergy and clinical immunology.

[520]  J. Burnie,et al.  Immunoblot fingerprinting Aspergillus fumigatus. , 1989, JIM - Journal of Immunological Methods.

[521]  P. Greenberger,et al.  The effects of age on isotypic antibody responses to Aspergillus fumigatus: implications regarding in vitro measurements. , 1989, The Journal of laboratory and clinical medicine.

[522]  J. Cohen,et al.  Invasive aspergillosis: clinical and pathological features of a new animal model. , 1989, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[523]  S. Clissold,et al.  Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses. , 1989, Drugs.

[524]  J. Bouchara,et al.  Binding of fibrinogen to the pathogenic Aspergillus species. , 1988, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[525]  C. Leslie,et al.  Morphological studies on clinical isolates of Aspergillus fumigatus. , 1988, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[526]  F. Matsubara,et al.  Demonstration of antigenemia in patients with invasive aspergillosis by biotin-streptavidin enzyme-linked immunosorbent assay. , 1988, The Journal of laboratory and clinical medicine.

[527]  A. Schaffner,et al.  Gamma-interferon restores listericidal activity and concurrently enhances release of reactive oxygen metabolites in dexamethasone-treated human monocytes. , 1988, The Journal of clinical investigation.

[528]  J. Graybill,et al.  Pharmacokinetics of itraconazole following oral administration to normal volunteers , 1988, Antimicrobial Agents and Chemotherapy.

[529]  J. Ryan,et al.  Effect of immunosuppression and amphotericin B on Aspergillus antigenemia in an experimental model. , 1988, The Journal of infectious diseases.

[530]  J. Bennett,et al.  Lectin-like attachment sites on murine pulmonary alveolar macrophages bind Aspergillus fumigatus conidia. , 1988, The Journal of infectious diseases.

[531]  P. Greenberger,et al.  Immune responses to Aspergillus in cystic fibrosis. , 1988, The Journal of allergy and clinical immunology.

[532]  J. C. Rhodes,et al.  Elastase production in clinical isolates of Aspergillus. , 1988, Diagnostic microbiology and infectious disease.

[533]  P. Waring,et al.  PREVENTION OF GRAFT‐VERSUS‐HOST DISEASE BY TREATMENT OF BONE MARROW WITH GLIOTOXIN IN FULLY ALLOGENEIC CHIMERAS AND THEIR CYTOTOXIC T CELL REPERTOIRE , 1988, Transplantation.

[534]  D. Kennedy,et al.  Chronic Fungal Sinusitis in Apparently Normal Hosts , 1988, Medicine.

[535]  R. Slavin,et al.  A pathologic study of allergic bronchopulmonary aspergillosis. , 1988, The Journal of allergy and clinical immunology.

[536]  H. Bossche,et al.  Aspergillus and Aspergillosis , 1988, Springer US.

[537]  Taylor Ml,et al.  Partial characterization of a rapidly released antigenic/allergenic component (Ag 5) of Aspergillus fumigatus. , 1988, The Journal of allergy and clinical immunology.

[538]  W. Carlton,et al.  Acute toxicity of gliotoxin in hamsters. , 1988, Toxicology letters.

[539]  R. Larson,et al.  Recurrent fungal pneumonias in patients with acute nonlymphocytic leukemia undergoing multiple courses of intensive chemotherapy. , 1988, The American journal of medicine.

[540]  H. Schønheyder,et al.  Clinical and serological survey of pulmonary aspergillosis in patients with cystic fibrosis. , 1988, International archives of allergy and applied immunology.

[541]  E. Wilson,et al.  Characterization of Purified Wall Antigens Obtained from Aspergillus Species , 1988 .

[542]  H. Geerts,et al.  The Molecular Basis for Itraconazole’s Activity against Aspergillus Fumigatus , 1988 .

[543]  J. Fransen,et al.  Modèles animaux d'immunodépression dans l'étude des mycoses et des antifongiques , 1988 .

[544]  P. Punt,et al.  A vector for Aspergillus transformation conferring phleomycin resistance. , 1988 .

[545]  M. L. Taylor,et al.  Partial characterization of a rapidly released antigenic/allergenic component (Ag 5) of Aspergillus fumigatus. , 1988, The Journal of allergy and clinical immunology.

[546]  J. Brouwer Detection of antibodies against Aspergillus fumigatus: comparison between double immunodiffusion, ELISA and immunoblot analysis. , 1988, International archives of allergy and applied immunology.

[547]  F. Beaumont Clinical manifestations of pulmonary Aspergillus infections. , 1988, Mycoses.

[548]  H. Schønheyder,et al.  Serum antibodies to Aspergillus fumigatus catalase in patients with cystic fibrosis. , 1988, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology.

[549]  V. Kurup,et al.  Isolation and characterization of a relevant Aspergillus fumigatus antigen with IgG- and IgE-binding activity. , 1988, International archives of allergy and applied immunology.

[550]  E. Wilson,et al.  Evaluation of a test to detect circulating Aspergillus fumigatus antigen in a survey of immunocompromised patients with proven or suspected invasive disease. , 1987, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[551]  A. Seaton,et al.  Inhibition of phagocyte migration and spreading by spore diffusates of Aspergillus fumigatus. , 1987, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[552]  M. Shepherd,et al.  The effects of azole and polyene antifungals on the plasma membrane enzymes of Candida albicans. , 1987, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[553]  P. Cole,et al.  Comparison of narrow section computed tomography and plain chest radiography in chronic allergic bronchopulmonary aspergillosis. , 1987, Clinical radiology.

[554]  B. Kramer,et al.  Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients. , 1987, The American journal of medicine.

[555]  J. Longbottom,et al.  Characterization of a second major antigen Ag 13 (antigen C) of Aspergillus fumigatus and investigation of its immunological reactivity. , 1987, Clinical and experimental immunology.

[556]  A. Schaffner,et al.  Glucocorticoid-induced impairment of macrophage antimicrobial activity: mechanisms and dependence on the state of activation. , 1987, Reviews of infectious diseases.

[557]  J. Bennett,et al.  Oxidative killing of Aspergillus fumigatus proceeds by parallel myeloperoxidase-dependent and -independent pathways , 1987, Infection and immunity.

[558]  J. Wingard,et al.  Aspergillus infections in bone marrow transplant recipients. , 1987, Bone marrow transplantation.

[559]  R. Patterson,et al.  Allergic bronchopulmonary aspergillosis. Model of bronchopulmonary disease with defined serologic, radiologic, pathologic and clinical findings from asthma to fatal destructive lung disease. , 1987, Chest.

[560]  D. Hume,et al.  Selective resistance of bone marrow-derived hemopoietic progenitor cells to gliotoxin. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[561]  A. Seaton,et al.  Resistance of spores of Aspergillus fumigatus to ingestion by phagocytic cells. , 1987, Thorax.

[562]  R. Hruban,et al.  Radiologic-pathologic correlation of the CT halo sign in invasive pulmonary aspergillosis. , 1987, Journal of computer assisted tomography.

[563]  J. Bennett,et al.  Receptor-mediated clearance of Aspergillus galactomannan. , 1987, The Journal of infectious diseases.

[564]  G. Lopez-Berestein Liposomes as carriers of antimicrobial agents , 1987, Antimicrobial Agents and Chemotherapy.

[565]  A. Seaton,et al.  Suppression of host defences by Aspergillus fumigatus. , 1987, Thorax.

[566]  S. Gerson,et al.  Serodiagnosis of invasive aspergillosis in patients with hematologic malignancy: validation of the Aspergillus fumigatus antigen radioimmunoassay. , 1987, The Journal of infectious diseases.

[567]  R. Oliver,et al.  Transformation of Aspergillus based on the hygromycin B resistance marker from Escherichia coli. , 1987, Gene.

[568]  P. Marichal,et al.  Anti-Candida drugs--the biochemical basis for their activity. , 1987, Critical reviews in microbiology.

[569]  S. Kim,et al.  Galactomannan antigenemia and antigenuria in aspergillosis: studies in patients and experimentally infected rabbits. , 1987, The Journal of infectious diseases.

[570]  B. Dupont,et al.  Early experience with itraconazole in vitro and in patients: pharmacokinetic studies and clinical results. , 1987, Reviews of infectious diseases.

[571]  J. Bolard How do the polyene macrolide antibiotics affect the cellular membrane properties? , 1986, Biochimica et biophysica acta.

[572]  J. Bennett,et al.  Inhibition of complement by culture supernatants of Aspergillus fumigatus. , 1986, The Journal of infectious diseases.

[573]  J. Jones,et al.  The role of bronchoalveolar lavage in the diagnosis of invasive pulmonary aspergillosis. , 1986, American journal of clinical pathology.

[574]  T. Ganz,et al.  In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages. , 1986, The Journal of infectious diseases.

[575]  A. Schaffner,et al.  In vitro susceptibility of fungi to killing by neutrophil granulocytes discriminates between primary pathogenicity and opportunism. , 1986, The Journal of clinical investigation.

[576]  V. Yu,et al.  Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results from a three-year prospective study. , 1986, The American journal of medicine.

[577]  M. Moody,et al.  Aspergillus sinusitis in cancer patients , 1986, Cancer.

[578]  J. Longbottom Antigens and allergens of Aspergillus fumigatus. II. Their further identification and partial characterization of a major allergen (Ag 3). , 1986, The Journal of allergy and clinical immunology.

[579]  G. Lopez-Berestein Liposomal amphotericin B in the treatment of fungal infections. , 1986, Annals of internal medicine.

[580]  J. Longbottom,et al.  Characterization of a major antigenic component of Aspergillus fumigatus. , 1986, Clinical and experimental immunology.

[581]  R. Patterson,et al.  Allergic bronchopulmonary aspergillosis. Natural history and classification of early disease by serologic and roentgenographic studies. , 1986, Archives of internal medicine.

[582]  H. Schønheyder,et al.  Binding of C-reactive protein to Aspergillus fumigatus fractions. , 1986, Journal of medical microbiology.

[583]  S. Opal,et al.  Efficacy of infection control measures during a nosocomial outbreak of disseminated aspergillosis associated with hospital construction. , 1986, The Journal of infectious diseases.

[584]  F. Rhame Endemic Nosocomial Filamentous Fungal Disease: A Proposed Structure for Conceptualizing and Studying the Environmental Hazard , 1986, Infection Control & Hospital Epidemiology.

[585]  T. Rogers Infections in Hematologic Malignancy , 1986, Infection Control & Hospital Epidemiology.

[586]  A. Müllbacher,et al.  The effect of gliotoxin upon macrophage function. , 1986, International journal of immunopharmacology.

[587]  V. Kurup,et al.  A partially purified glycoprotein antigen from Aspergillus fumigatus. , 1986, International archives of allergy and applied immunology.

[588]  H. Kauffman,et al.  Class-Specific Antibody Determination against Aspergillus fumigatus by Means of the Enzyme-Linked Immunosorbent Assay , 1986 .

[589]  R. Einarsson,et al.  Detection of allergens in mould and mite preparations by a nitrocellulose electroblotting technique. , 1986, International archives of allergy and applied immunology.

[590]  E. Fishman,et al.  Invasive pulmonary aspergillosis in acute leukemia: characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis. , 1985, Radiology.

[591]  S. Levitz,et al.  A rapid colorimetric assay of fungal viability with the tetrazolium salt MTT. , 1985, The Journal of infectious diseases.

[592]  V. Andriole,et al.  The diagnosis of invasive aspergillosis by an enzyme-linked immunosorbent assay for circulating antigen. , 1985, The Journal of infectious diseases.

[593]  A. Schaffner Therapeutic concentrations of glucocorticoids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to gamma interferon. , 1985, The Journal of clinical investigation.

[594]  J. Burnie,et al.  Immunoblot analysis of serological responses in invasive aspergillosis. , 1985, Journal of clinical pathology.

[595]  Luis Carrasco,et al.  Modification of membrane permeability during Semliki Forest virus infection. , 1985, Virology.

[596]  D. Visscher,et al.  Diagnosis of pulmonary infection caused by Aspergillus: usefulness of respiratory cultures. , 1985, The Journal of infectious diseases.

[597]  K. Yokota,et al.  Studies on toxin of Aspergillus fumigatus, XXI.Site of binding of Asp-hemolysin to erythrocytes and mechanism of inhibition of hemolysis , 1985 .

[598]  S. Levitz,et al.  Mechanisms of resistance of Aspergillus fumigatus Conidia to killing by neutrophils in vitro. , 1985, The Journal of infectious diseases.

[599]  R. Diamond,et al.  Neutrophil chemotactic responses induced by fresh and swollen Rhizopus oryzae spores and Aspergillus fumigatus conidia , 1985, Infection and immunity.

[600]  P. Waring,et al.  Identification of an agent in cultures of Aspergillus fumigatus displaying anti-phagocytic and immunomodulating activity in vitro. , 1985, Journal of general microbiology.

[601]  C. Escarmís,et al.  The mode of action of restrictocin and mitogillin on eukaryotic ribosomes. Inhibition of brain protein synthesis, cleavage and sequence of the ribosomal RNA fragment. , 1985, European journal of biochemistry.

[602]  J. Bennett,et al.  Galactofuranosyl groups are immunodominant in Aspergillus fumigatus galactomannan. , 1985, Molecular immunology.

[603]  K. Yokota,et al.  Studies on Toxin of Aspergillus fumigatus , 1985 .

[604]  D. Schlessinger,et al.  Involvement of oxidative damage in erythrocyte lysis induced by amphotericin B , 1985, Antimicrobial Agents and Chemotherapy.

[605]  M. Healy,et al.  A method to determine significant levels of immunoglobulin G to Aspergillus fumigatus antigens in an ELISA system and a comparison with counterimmunoelectrophoresis and double diffusion techniques. , 1985, Journal of immunoassay.

[606]  S. Levitz,et al.  In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus. , 1984, The Journal of infectious diseases.

[607]  W. Wilson,et al.  Fungal sinusitis in healthy and immunocompromised individuals. , 1984, American journal of clinical pathology.

[608]  F. Khan,et al.  Aspergillomas complicating sarcoidosis. A prospective study in 100 patients. , 1984, Chest.

[609]  K. Yokota,et al.  Studies on Toxin of Aspergillus fumigatus XVII. Changes of Biological Activities Accompanied by the Inactivation of Asp-hemolysin , 1984 .

[610]  R. Slavin,et al.  Aspergillus fumigatus spore concentration in outside air: Cardiff and St Louis compared , 1984, Clinical allergy.

[611]  F. Cockerill Respiratory Infections: Diagnosis and Management , 1984 .

[612]  S. Albelda,et al.  Role of fiberoptic bronchoscopy in the diagnosis of invasive pulmonary aspergillosis in patients with acute leukemia. , 1984, The American journal of medicine.

[613]  A. Müllbacher,et al.  Immunosuppression in vitro by a metabolite of a human pathogenic fungus. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[614]  H. Kauffman,et al.  The allergenic and antigenic properties of spore extracts of Aspergillus fumigatus: a comparative study of spore extracts with mycelium and culture filtrate extracts. , 1984, The Journal of allergy and clinical immunology.

[615]  E. Reiss,et al.  Current trends in immunodiagnosis of candidiasis and aspergillosis. , 1984, Reviews of infectious diseases.

[616]  B. Strom,et al.  Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. , 1984, Annals of internal medicine.

[617]  S. Levitz,et al.  Killing of Aspergillus fumigatus spores and Candida albicans yeast phase by the iron-hydrogen peroxide-iodide cytotoxic system: comparison with the myeloperoxidase-hydrogen peroxide-halide system , 1984, Infection and Immunity.

[618]  G. Lopez-Berestein,et al.  In vitro antifungal activities of amphotericin B and liposome-encapsulated amphotericin B , 1984, Antimicrobial Agents and Chemotherapy.

[619]  J. Graybill,et al.  Experimental murine aspergillosis. Comparison of amphotericin B and a new polyene antifungal drug, SCH 28191. , 1984, The American review of respiratory disease.

[620]  M. Kothary,et al.  Correlation of elastase production by some strains of Aspergillus fumigatus with ability to cause pulmonary invasive aspergillosis in mice , 1984, Infection and immunity.

[621]  K. Yokota,et al.  Studies on the Toxin of Aspergillus fumigatus , 1976, Microbiology and immunology.

[622]  K. Yokota,et al.  Studies on toxin of Aspergillus fumigatus. XIX. Biochemical alteration of sera after Asp-hemolysin inoculation or Aspergillus infection in mice. , 1984 .

[623]  J. Kalbfleisch,et al.  Allergic bronchopulmonary aspergillosis in cystic fibrosis. , 1984, The Journal of allergy and clinical immunology.

[624]  G. Filice,et al.  Antigen detection in the diagnosis of invasive aspergillosis. Utility in controlled, blinded trials. , 1983, Annals of internal medicine.

[625]  A. Schaffner,et al.  Killing of Aspergillus spores depends on the anatomical source of the macrophage , 1983, Infection and immunity.

[626]  V. Kurup,et al.  Antigens of Aspergillus fumigatus. II. Electrophoretic and clinical studies. , 1983, Immunology.

[627]  B. Chaudhary,et al.  Pathogenicity of Aspergillus fumigatus in Chicks, Guinea Fowl, Rabbits and Mice/Pathogenität von Aspergillus fumigatus bei Hühnern, Perlhühnern, Kaninchen und Mäusen , 1983, Mykosen.

[628]  C. Stratton,et al.  Invasive aspergillosis in renal transplant recipients: correlation with corticosteroid therapy. , 1983, The Journal of infectious diseases.

[629]  A. Streifel,et al.  Aspergillus fumigatus and other thermotolerant fungi generated by hospital building demolition , 1983, Applied and environmental microbiology.

[630]  J. Longbottom Antigens/allergens of Aspergillus fumigatus. Identification of antigenic components reacting with both IgG and IgE antibodies of patients with allergic bronchopulmonary aspergillosis. , 1983, Clinical and experimental immunology.

[631]  C. Haudenschild,et al.  Mechanisms of destruction of Aspergillus fumigatus hyphae mediated by human monocytes. , 1983, The Journal of infectious diseases.

[632]  D. C. Aldridge,et al.  Fungal metabolites II , 1983 .

[633]  R. Diamond Inhibition of monocyte-mediated damage to fungal hyphae by steroid hormones. , 1983, The Journal of infectious diseases.

[634]  E. Wilson,et al.  A Comparison of Surface and Cytoplasmic Antigens of Aspergillus fumigatus in an Enzyme‐Linked Immunosorbent Assay (ELISA) , 1982, Mykosen.

[635]  R. Clark,et al.  Damage to Aspergillus fumigatus and Rhizopus oryzae Hyphae by Oxidative and Nonoxidative Microbicidal Products of Human Neutrophils In Vitro , 1982, Infection and immunity.

[636]  H. Israel,et al.  Sarcoidosis and aspergilloma. The role of surgery. , 1982, Chest.

[637]  A. Schaffner,et al.  Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. , 1982, The Journal of clinical investigation.

[638]  H. Deeg,et al.  Alveolar macrophage kinetics and function after interruption of canine marrow function. , 1982, The American review of respiratory disease.

[639]  J. Richard,et al.  Vaccination studies of aspergillosis in turkeys: subcutaneous inoculation with several vaccine preparations followed by aerosol challenge exposure. , 1982, American journal of veterinary research.

[640]  R. Patterson,et al.  Allergic bronchopulmonary aspergillosis: staging as an aid to management. , 1982, Annals of internal medicine.

[641]  G. Snider,et al.  Chronic Necrotizing Pulmonary Aspergillosis: A Discrete Clinical Entity , 1982, Medicine.

[642]  R. Patterson,et al.  Application of enzyme-linked immunosorbent assay (ELISA) in diagnosis of allergic bronchopulmonary aspergillosis. , 1982, The Journal of laboratory and clinical medicine.

[643]  A. Polak,et al.  Combination therapy of experimental candidiasis, cryptococcosis and aspergillosis in mice. , 1982, Chemotherapy.

[644]  Robert A. Samson,et al.  Introduction to food-borne fungi. , 1989 .

[645]  D. Armstrong,et al.  Invasive Aspergillosis: Progress in early diagnosis and treatment , 1981 .

[646]  P. Gorin,et al.  Cell constituents of mycelia and conidia of Aspergillus fumigatus , 1981 .

[647]  V. Kurup,et al.  Antigens of aspergillus fumigatus. 1. Purification of a cytoplasmic antigen reactive with sera of patients with aspergillus-related disease. , 1981, Clinical and experimental immunology.

[648]  R. Hoffmann,et al.  Allergic bronchopulmonary aspergillosis in corticosteroid-dependent asthmatics. , 1981, The Journal of allergy and clinical immunology.

[649]  A. Bayer,et al.  Fungal pneumonia (Part 4): invasive pulmonary aspergillosis. , 1981, Chest.

[650]  C. Andrews,et al.  Immunodiagnosis of invasive pulmonary aspergillosis in rabbits. Fungal antigen detected by radioimmunoassay in bronchoalveolar lavage fluid. , 1981, The American review of respiratory disease.

[651]  D. Williams,et al.  Immunologic studies of disseminated infection with Aspergillus fumigatus in the nude mouse. , 1981, The Journal of infectious diseases.

[652]  M. Baggiolini,et al.  Defective Aspergillus killing by neutrophil leucocytes in a case of systemic aspergillosis. , 1981, Clinical and experimental immunology.

[653]  L. Travassos,et al.  Chemical structure of the d-galacto-d-mannan component from hyphae of Aspergillus niger and other Aspergillus spp , 1980 .

[654]  D. Mackenzie,et al.  The preparation and partial purification of fractions from mycelial fungi with antigenic activity. , 1980, Molecular immunology.

[655]  E. Wilson,et al.  Preparation of Aspergillus fumigatus antigens and their analysis by two-dimensional immunoelectrophoresis. , 1980, Journal of medical microbiology.

[656]  M. Weiner Antigenemia detected by radioimmunoassay in systemic aspergillosis. , 1980, Annals of internal medicine.

[657]  M. Nalesnik,et al.  Significance of Aspergillus species isolated from respiratory secretions in the diagnosis of invasive pulmonary aspergillosis , 1980, Journal of clinical microbiology.

[658]  G. Medoff,et al.  Demonstration of antigenemia in patients with invasive aspergillosis by solid phase (protein A-rich Staphylococcus aureus) radioimmunoassay. , 1979, The American journal of medicine.

[659]  J. Richard,et al.  Exposure of rabbits to spores of Aspergillus fumigatus or Penicillium sp: survival of fungi and microscopic changes in the respiratory and gastrointestinal tracts. , 1979, American journal of veterinary research.

[660]  E. Reiss,et al.  Galactomannan antigenemia in invasive aspergillosis , 1979, Infection and immunity.

[661]  M. Weiner,et al.  Immunodiagnosis of systemic aspergillosis. I. Antigenemia detected by radioimmunoassay in experimental infection. , 1979, The Journal of laboratory and clinical medicine.

[662]  A. Steere,et al.  Invasive aspergillosis in acute leukemia: correlation with nose cultures and antibiotic use. , 1979, Annals of internal medicine.

[663]  Arnow Pm,et al.  Pumonary aspergillosis during hospital renovation. , 1978 .

[664]  W. Solomon,et al.  Airborne Aspergillus fumigatus levels outside and within a large clinical center. , 1978, The Journal of allergy and clinical immunology.

[665]  I. Bhatia,et al.  Experimental aspergillosis in monkeys. , 1978, Sabouraudia.

[666]  R. Krzesicki,et al.  Damage to hyphal forms of fungi by human leukocytes in vitro. A possible host defense mechanism in aspergillosis and mucormycosis. , 1978, The American journal of pathology.

[667]  B. Cooper,et al.  Serum IgE and IgG antibody activity against Aspergillus fumigatus as a diagnostic aid in allergic bronchopulmonary aspergillosis. , 1978, The American review of respiratory disease.

[668]  E. Reiss,et al.  Invasive aspergillosis: antiserum for circulating antigen produced after immunization with serum from infected rabbits , 1978, Infection and immunity.

[669]  H. Bender,et al.  Hemoptysis and pulmonary aspergilloma: operative versus nonoperative treatment. , 1978, The Annals of thoracic surgery.

[670]  R. Patterson,et al.  The assessment of immunologic and clinical changes occurring during corticosteroid therapy for allergic bronchopulmonary aspergillosis. , 1978, The American journal of medicine.

[671]  P. Arnow,et al.  Pumonary aspergillosis during hospital renovation. , 1978, The American review of respiratory disease.

[672]  G R Smith,et al.  Aspergillus fumigatus: a possible relationship between spore size and virulence for mice. , 1977, Journal of general microbiology.

[673]  P. Bardalaye,et al.  Chemical structure of the galactomannan from the cell wall of Aspergillus niger. , 1977, The Journal of biological chemistry.

[674]  B. Cooper,et al.  Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. , 1977, Annals of internal medicine.

[675]  L. White Germination of Aspergillus fumigatus conidia in the lungs of normal and cortisone-treated mice. , 1977, Sabouraudia.

[676]  A. Seaton,et al.  Sources and incidence of airborne Aspergillus fumigatus (Fres) , 1976, Clinical allergy.

[677]  L. White,et al.  Acquired immunity to Aspergillus fumigatus , 1976, Infection and immunity.

[678]  K. Turner,et al.  The pathogenesis of experimental pulmonary aspergillosis in normal and cortisone‐treated rats , 1976, The Journal of pathology.

[679]  J E Bennett,et al.  Aspergillus infections in cancer patients. Association with fireproofing materials in a new hospital. , 1976, JAMA.

[680]  L. White,et al.  Chitin assay used to demonstrate renal localization and cortisone-enhanced growth of Aspergillus fumigatus mycelium in mice , 1975, Infection and immunity.

[681]  L. Young,et al.  Aspergillosis complicating neoplastic disease. , 1973, The American journal of medicine.

[682]  G. Smith,et al.  Experimental aspergillosis in mice: aspects of resistance , 1972, Epidemiology and Infection.

[683]  J. Bennett,et al.  Invasive aspergillosis. Absence of detectable antibody response. , 1971, The American review of respiratory disease.

[684]  Juneann W. Murphy,et al.  Cell-mediated immunity. , 1971 .

[685]  I. Azuma,et al.  Biochemical and immunological studies on Aspergillus. 3. Chemical and immunological properties of glycopeptide obtained from Aspergillus fumigatus. , 1971, Japanese journal of microbiology.

[686]  H. Sidransky,et al.  The pathogenesis of experimental pulmonary aspergillosis. An ultrastructural study of alveolar macrophages after phagocytosis of a flavus spores in vivo. , 1971, The American journal of pathology.

[687]  R. Lehrer,et al.  Interaction of Aspergillus fumigatus Spores with Human Leukocytes and Serum , 1970, Infection and immunity.

[688]  D. K. Sandhu,et al.  Effect of cortisone on bronchopulmonary aspergillosis in mice exposed to spores of various Aspergillus species. , 1970, Sabouraudia.

[689]  A. Ostrow,et al.  Sarcoidosis and aspergilloma. , 1969, The American journal of medicine.

[690]  H. Sidransky,et al.  Lysosomal Stability during Phagocytosis of Aspergillus flavus Spores by Alveolar Macrophages of Cortisone-Treated Mice , 1968, Science.

[691]  J. Fruit,et al.  [Identification of chymotryptic activity in remarkable fractions of an antigenic extract of Aspergillus fumigatus. Significance for the immunologic diagnosis of aspergillosis]. , 1967, Revue d'immunologie et de therapie antimicrobienne.

[692]  W. Charney Microbial transformations of steroids , 1967 .

[693]  J. Uriel,et al.  [Characterization of types of enzymatic activities in antigenic extracts of Aspergillus fumigatus after electrophoresis and immunoelectrophoresis in agarose]. , 1966, Annales de l'Institut Pasteur.

[694]  J. Uriel,et al.  Characterization of enzymatic activity types in antigenic extracts of A. fumigatus by agar electrophoresis and immunoelectrophoresis. , 1966 .

[695]  Y. Clayton,et al.  FUNGI IN THE AIR OF HOSPITAL WARDS. , 1963, Journal of general microbiology.

[696]  A. Delaunay,et al.  Complement and phagocytosis. , 1945 .